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Abstract 
 
The primary features of type 2 diabetes (T2D) are both insulin resistance and 
impaired beta cell function. Abnormal glucose handling and variable degrees of 
peripheral insulin resistance characterise T2D. Skeletal muscle is the largest 
insulin-regulated glucose sink in the body and represents approximately 80% of 
whole body insulin-stimulated glucose uptake. As a result a fundamental aspect 
of T2D is abnormal glucose disposal in contractile tissues triggering metabolic 
dysregulation and glucotoxic side effects. The significance of skeletal muscle to 
T2D has prompted research into the perturbed glucose handling mechanisms in 
suitable animal models, such as muscle tissues from the spontaneously diabetic 
Goto-Kakizaki rat. Highly sensitive protein analysis techniques such as 
fluorescence difference in-gel electrophoresis (DIGE) and electrospray ionization 
liquid chromatography mass spectrometry (ESI LC/MS) were employed to 
analysis the diabetic muscle tissue proteome and sub-proteome. A differential 
  12
expression pattern was observed for proteins involved in glycolysis, the citric acid 
cycle, oxidative phosphorylation, lipolytic catabolism, the contractile apparatus, 
cellular detoxification mechanisms and the stress response. These findings 
demonstrate a perturbed protein expression pattern in diabetic skeletal muscle, 
which reflects underlying molecular alterations. Over all this study has supplied 
several potential biomarkers of T2D and adds further knowledge to the 
mechanism of a complex metabolic disorder.  
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Chapter 1 
Introduction 
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1 Introduction  
1.1 Muscle 
Movement is a diverse and fundamental trait of living organisms. In higher 
organisms muscle contraction is responsible for movement and has evolved to 
meet a wide variety of functions that require a vast spectrum of differences in 
execution. Muscle tissue is responsible for providing and facilitating some of the 
body’s most important functions such as contraction, relaxation, metabolism, 
heat production, and energy conservation. As a result, skeletal muscle accounts 
for approximately 40% of mammalian body mass and at least 25% of whole body 
protein turnover occurs in this tissue (Waterlow, J 1976). Muscle can be 
categorised into four distinct groups (skeletal, cardiac, smooth and myoepithelial) 
based on morphology, location, and performance and in their mechanisms of 
activation in order to generate contraction. Both skeletal muscle and cardiac 
muscle are striated: they have striations, or strips that extend across the width of 
the muscle fibres. Skeletal muscles are generally attached to bone. It is this 
tissue that is responsible for short bursts of voluntary movement or prolonged 
contractions. Continuous activity is the main characteristic of cardiac muscle. It 
can function continuously as it is highly resistant to fatigue due to its large 
number of mitochondria. Intercalated disks are unique to cardiac tissue and 
function in maintaining the synchronised contraction of the short, striated muscle 
fibres. Both cardiac and smooth muscle are involuntary, as they are not 
controlled by the somatic nervous system. Unlike cardiac and skeletal muscle 
fibres, smooth muscle fibres are not striated or rectangular, but spindle shaped. 
  15
Smooth muscle fibres are over lapped and layered unlike the bundling 
experienced by skeletal and cardiac tissues. Myoepithelial cells form the basal 
layer of the epithelium in mammary glands, lactiferous sinuses and ducts. They 
can contract and they unequivocally composed of the key fundamental structural 
proteins involved in muscle contraction. It is the different arrangements of the 
contractile apparatus in each muscle type that provides their contractile 
specificity. 
 
1.1.1 Skeletal Muscle  
Skeletal muscle is anchored to the skeleton by tendons and is used to affect 
movement and posture by contraction or relaxation of the muscle. Muscle tissue 
is created by the formation of bundles of fibres sheathed in connective tissue. 
Each muscle cell or fibre can vary greatly in size, with human skeletal muscle 
fibres measuring up to several centimeters in length and 100m in diameter. 
Figure 1.1 shows how skeletal muscle is made up of many individual fibres. Each 
fibre consists of approximately a thousand rectangular rod-like structures, known 
as myofibrils (Engel, et al., 2005). Each fibre is multinucleated cellular structure, 
formed by the fusion of several myoblast cells during development. The 
elongation of the growing myofibre navigates towards tendon cells giving rise to 
stable attachments between muscles, epidermis and cuticle (Schejter et al., 
2010) The sarcomere is the core element of the contractile apparatus and is 
found in the myofibril. The sarcomere is roughly 2.4m in length and is made up 
of thick and thin contractile myofilaments, which occur, in an overlapped 
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arrangement. The thick and thin filaments found in the sarcomere are also known 
as the myosin and actin filaments, respectively. The overlapped arrangement of 
these filaments generates a regular pattern of light and dark strips, which results 
in the striated appearance of skeletal and cardiac muscle.  
Figure 1.1: The basic structure of muscle. A complex unit comprising of 
bundles of multinucleate cells called fibres.
http://training.seer.cancer.gov/module_anatomy/
 
The sarcomere is often divided up into different zones to illustrate how it behaves 
during muscle contraction. The Z-line separates each sarcomere. The H-zone is 
the center of the sarcomere and the M-line is where adjacent myosin filaments 
anchor on to each other. The H-zone appears only when the sarcomere is in a 
resting state. The darker A-bands are where myosin filaments align and the 
lighter I-bands are where actin filaments align. When muscle contracts the H-
zone and I-band both decrease as the Z-lines are pulled towards each other. 
Figure 1.2 shows a longitudinal section through skeletal muscle. 
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Figure 1.2: Longitudinal section of skeletal 
muscle.  
http://www.drsharma.ca/tag/skeletal-muscle
 
1.1.2 Sliding Filament Hypothesis 
Thin filaments are made up of two actin strands, which intertwine to form an 
alpha helical structure. Bound to the helix are the proteins tropomyosin and 
troponin. The protein tropomyosin inhibits muscle contraction by blocking the 
interaction of myosin with actin. Troponin is a thin-filament protein that regulates 
the response of myofilaments to calcium. Troponin is a complex composed of 
TnT (the tropomyosin binding subunit), TnC (the calcium binding subunit) and TnI 
(prevents the myosin head attachment to F-actin). In 1942 Straub discovered two 
conformational forms of actin, one as a monomer (globular or G-actin) and the 
other as a polymer (filamentous or F-actin). F-actin is the type of actin present in 
skeletal muscle. According to Asakura (1961) polymerisation of the filamentous 
actin is associated with ATP hydrolysis. Upon stimulation, Ca2+ is released from 
internal stores and binds to troponin, which induces a conformational change of 
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tropomyosin, moving it from actin allowing actin-myosin interaction (Reedy et al., 
1965; Moore et al., 1970).  
The thick filament is composed of a bundle of protein strands called myosin 
filaments. Myosin is responsible for approximately one third of skeletal muscle 
mass. Myosin can be separated into two components via tryptic digestion (Szent-
Gyorgi, 1953).  Light meromyosin (LMM) is the smaller of the two stands and 
heavy meromyosin (HMM) is the bigger. LMM is utilised during filament 
formation, and HMM contains the sites for actin interactions. Each myosin 
filament consists of two globular heads (also known as the myosin head), and a 
single tail formed by two strands twisted to create a double helical arrangement. 
The tail of each myosin molecule lies along the axis of the thick filament, and the 
two globular heads extend out to the sides, to form the cross-bridges that occur 
during muscle action with specialised active sites in the actin filaments. Each 
myosin head contains two binding sites, one for ATP and one for actin. The ATP 
binding site contains ATPase which binds and hydrolyses the ATP (Nigg and 
Herzog, 1994).  The hydrolysis of ATP (the conversion of ATP to ADP via the 
loss of one phosphate) provides the energy for the cross-bridge to move. In other 
words the myosin head pivots and pulls the actin filament towards the centre of 
the sarcomere. This motion is commonly known as the power stroke (Reedy, et 
al., 2000). The ADP, now present in the myosin cleft, is replaced with another 
ATP molecule which forces the actin and myosin apart. The hydrolysis of this 
ATP molecule will begin another binding overlapping cycle pushing the actin 
filament along and resulting in contraction of the cell. When the ATP is released 
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the myosin head returns to its low energy form configuration. The relaxation 
changes the angle of the myosin head to the fibrous myosin tail (Huxley, 1954). 
Shortening of the sarcomere and contraction will continue until there is a lack of 
calcium ions or ATP (Figure 1.3). The higher the frequency of this shortening of 
the sarcomere, the shorter the myofibrils become, allowing the entire muscle to 
contract and also grading the strength of the contraction (Huxley, et al., 2004).  
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Myofibril
Myosin (thick) 
Filaments
Actin (thin) 
Filaments
A
B
Figure 1.3: A schematic representation of the microstructure of 
the myofibril. Each Muscle fibre (or cell) is made up  of about 75-120 
rod-like structures, termed myofibrils. A Illustrates the banding pattern 
of the contractile unit, the sarcomere. The I-bands of alpha-actinin and 
desmin mark the borders between the sarcomeres. The Z-lines are 
made up of actin. The A-band is made from myosin and actin 
filaments. B shows the arrangement structure of the thick and thin 
filaments within a single sarcomere.
Adapted from: http://www.sport-fitness-advisor.com/muscle-
anatomy.html
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 1.1.2.1  Excitation Contraction Coupling 
The association between excitation of the muscle cell membrane and contraction 
has been termed excitation-contraction coupling. Voluntary muscle contraction 
originates in the motor cortex of the brain and is conducted through the somatic 
nervous system as an electrical signal. Therefore, contraction starts at the 
neuromuscular junction. The neuromuscular junction is the point at which nerve 
and muscle meet. Here, the electrical signal must be converted into a chemical 
one in order for it to pass across the synapse between the motor neuron and the 
muscle. At the surface of the muscle fibre, the axon splits into a number of short 
invaginations containing synaptic vesicles. These synaptic vesicles, which can be 
seen in Figure 1.4, contain the neurotransmitter acetylcholine (ACh), which 
bridges the gap between the neuron and the muscle. ACh is a chemical 
substance which transmits nerve impulses across a synapse. The area of the 
muscle fibre membrane that is located directly beneath the axon is also folded 
into junctional folds, in a bid to increase the surface area of the membrane 
exposed to respond to the ACh. An action potential passes down the motor 
neuron and when it arrives at the axon terminal causes the release Ca2+ that in 
turn affects the release of the stored ACh, which traverses the synapse and 
binds to the post-synaptic acetylcholine receptors in the junctional folds. 
Activation of these receptors causes localised depolarisation (Farley et al. 1977) 
leading to the opening of sodium and potassium channels. Since more sodium 
enters the cytosol than potassium leaves the muscle, the sarcolemma becomes 
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depolarised (Hodgkin et al. 1960), causing an action potential that passes along 
the membrane into transverse tubules (T-tubules), which are invaginations of the 
sarcolemma between the termini of two sarcoplasmic reticuli.  
Figure 1.4: Contraction begins at the neuromuscular junction. 1 The 
neurotransmitter ACh is released from the axon and it then diffuses across 
the synaptic cleft and attaches to receptors on the sarcolemma.  2 An action 
potential is propagated along the sarcolemma and down the T-tubules. 3 
The action potential triggers the release of Ca2+ from the sarcoplasmic 
reticulum. 4 Ca2+  binds to tropomyosin allowing it to bind to actin which 
inititates contraction.
http://www.bio.miami.edu/~cmallery/150/neuro/c49x36contraction-
cycle.htm
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The two proteins of central importance in excitation-contraction coupling are the 
Ryanodine receptor 1 (skeletal isoform) (RyR1) and the 1s-Dihydropyridine 
receptor (skeletal isoform) (1s-DHPR).  The action potential is sensed by the II-
III loop of the voltage sensing 1s subunit of the DHP receptor, which is present 
in the T-tubules. Once depolarisation is detected the receptor undergoes a 
conformational change allowing it to interact with the cytoplasmic portion of the 
RyR1 receptor (Proenza et al. 2002), which is on the sarcoplasmic reticulum 
membrane. This reaction triggers the RyR to open its calcium channels allowing 
the influx of calcium ions into the cytoplasm of the muscle cell. These calcium 
ions interact with TpC causing structural changes to tropomyosin allowing for the 
interaction of the myosin head of the thick filament to interact with the actin of the 
thin filament (Tao et al. 1990). This interaction forms the cross bridges between 
the filaments (Huxley et al. 1954). The more filaments that the cross bridges 
occur in at any one time the shorter the myofibrils become, allowing not only the 
entire muscle to contract but also a grading of the strength of contraction. Once 
the sarcolemma returns to its resting potential the calcium channel RyR closes 
and various ATPases such as SERCA (sarcoplasmic (endoplasmic) reticulum 
calcium ATPase) removes calcium back into the sarcoplasmic reticulum 
(Heegaard et al. 1990). Because of the decline in the availability of calcium the 
calcium ions bound to troponin are released and tropomyosin returns to its 
normal conformation, which prevents any cross bridges from being formed and 
the muscle relaxes.  
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1.2 Glucose Metabolism 
Few physiological parameters are more vigilantly regulated in humans than blood 
glucose concentration. The main cellular mechanism that moderates blood 
glucose is insulin-stimulated glucose transport into skeletal muscle. Glucose is 
stored in skeletal muscle as glycogen where it is oxidized to produce energy. 
GLUT 4 is the paramount transporter protein, which specializes in glucose 
uptake and therefore plays a key role in regulating whole body glucose 
homeostasis. 
1.2.1 Glycolysis  
Glycolysis is the anaerobic catabolism of glucose. The mechanism involves the 
conversion of one molecule of glucose into two molecules of pyruvate. The C3 
pyruvate is then converted to acetyl coenzyme A (CoA), ready for entry into the 
citric acid cycle. Two ATP molecules are necessary for the reactions that occur in 
the priming stages of glycolysis. Glucose is phosphorylated to form glucose 6-
phosphate by ATP, which becomes ADP. This reaction is catalyzed by the 
enzyme hexokinase. Phosphoglucoisomerase then mediates the isomerization of 
glucose 6-phosphate to fructose 6-phosphate which involves the conversion of 
an aldose to a ketose.  The second ATP molecule then phosphorylates fructose 
6-phosphate to form fructose 1,6-bisphosphate and ADP. Phosphofructokinase 
catalyzes this step. The 6 carbon molecule fructose 1,6-bisphosphate is split into 
two 3 carbon molecules, glyceraldehyde 3-phosphate and dihydroxyacetone 
phosphate, by the enzyme aldolase. Glyceraldehyde-3-phosphate is converted to 
1,3-bisphosphoglycerate. This reaction is catalyzed by glyceraldehyde-3-
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phosphate dehydrogenase and uses inorganic phosphate and NAD+. NADH is 
the other product of this reaction. The oxidation of the aldehyde group of the 
glyceraldehyde 3-phosphate generates enough energy to make the conversion to 
1,3-bisphosphoglycerate. The energy is utilised in the generation of a new high-
energy phosphate bond. This new bond is now used to synthesize ATP. 
Phosphoglycerate kinase catalyzes the transfer of the phosphoryl group from the 
1,3-bisphosphoglycerate to ADP generating ATP and 3-phosphoglycerate. 2-
phosphoglycerate is generated from the movement of the phosphate group from 
carbon 3 to carbon 2 within the same molecule. The enzyme phosphoglycerate 
mutase is responsible for the shift from 3-phosphoglycerate to 2-
phosphoglycerate. The low-energy phosphate ester bond of 2-phosphoglycerate 
is converted to the high-energy phosphate bond of phosphoenolpyruvate (PEP) 
by the dehydration action of the enzyme enolase. The last reaction of glycolysis 
involves pyruvate kinase catalyzing the irreversible transfer of the phosphoryl 
group from PEP to ADP to form pyruvate and ATP. Glycolysis releases relatively 
little of the energy present in a glucose molecule, however the high density of 
glycolytic enzymes present in muscle tissue shows how the system is effective at 
releasing sufficient energy from the molecule under aerobic conditions. Much 
more of that trapped energy is released by the subsequent operation of the citric 
acid cycle and oxidative phosphorylation.  
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Figure 1.5: Summary of the enzymatic steps of glycolysis. The various enzymes and their 
biochemical reactions involved in the glycolytic pathway are listed in the flowchart (Ohlendieck, et 
al., 2010). The backround shows a bright field image of a transverse section through adult rabbit 
biceps femoris muscle. 
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 1.2.3 Citric Acid Cycle 
Acetyl CoA is one of the key intermediates in the interconversion of small organic 
acids. Acetyl CoA is formed by the oxidative decarboxylation of pyruvate with the 
release of CO2. The reaction is catalyzed by the pyruvate dehydrogenase 
enzyme complex (3 enzymes and 5 coenzymes). During the conversion of 
pyruvate to Acetyl CoA NAD+ is reduced to NADH. The pathway known as the 
citric acid cycle, the tricarboxylic acid cycle (TCA), or the Krebs cycle (after Hans 
Krebs who discovered it in the 1930s), carries out the oxidation of acetyl groups 
from acetyl CoA to CO2 with the production of four pairs of electrons.  The cycle 
operates in the mitochondria of eukaryotes and in the cytosol of prokaryotes. The 
cycle has eight stages.  
I. Citrate (6C) is formed from the irreversible condensation of acetyl CoA (2C) 
and oxaloacetate (4C) which is catalyzed by citrate synthase.  
II. Citrate is converted into isocitrate (6C) by an izomerisation catalyzed by 
aconitase.  
III. Isocitrate is oxidized to a-ketoglutarate (5C) and CO2 by isocitrate 
dehydrogenase. This is a mitochondrial enzyme that requires NAD+, which is 
reduced to NADH.  
IV. -Ketogluterate is oxidized to succinyl CoA (4C) and CO2 by the -
ketogluterate dehydrogenase complex. This complex utilises 3 enzymes NAD+ as 
a cofactor. 
V.  Succinyl CoA is converted to succinate (4C) by succinyl CoA synthase. The 
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reaction uses the energy from the cleavage of the succinyl-CoA bond to 
synthesize GTP from Pi and GDP. GTP is guanosine triphosphate one for which 
is equivalent to one ATP.  
VI. Succinate is oxidized to fumarate (4C) by succinate dehydrogenase. The 
only membrane-bound enzyme in the citric acid cycle is succinate 
dehydrogenase and is embedded in the inner mitochondrial membrane. FAD is 
tightly bound to the enzyme and is reduced to produce FADH2.  
VII. Fumarate is converted to malate (4C) by fumarase; this reaction is a 
rehydration reaction involving the addition of a water molecule.  
VIII. Malate is oxaloacetate (4C) by malate dehydrogenase. NAD+ is again 
required by the enzyme as a cofactor to accept the free pair of electrons and 
produce NADH.  
The NADH and FADH2 produced by the citric acid cycle are re-oxidized and the 
energy generated is used to synthesize ATP by oxidative phosphorylation. The 
citric acid cycle is portrayed diagrammatically in Figure 1.6.  
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Figure 1.6: Summary of the enzymatic steps of the citric acid cycle. The various enzymes and 
their biochemical reactions involved in the cycle are listed in the flowchart. 
http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/CellularRespiration.html 
1.2.4 Oxidative Phosphorylation and Electron Transport.  
Electron transport and oxidative phosphorylation occur in the inner membrane of 
mitochondria. These events re-oxidize the NADH and the FADH2 that arise from 
the citric acid cycle and glycolysis and trap the energy released as ATP. 
Oxidative phosphorylation is by far the major source of ATP in the cell. The 
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oxidation of a molecule involves the loss of electrons and reduction involves the 
gain of electrons. So if one molecule is oxidized another must be reduced.  
The oxidation of NADH releases sufficient energy to drive the synthesis of 
several molecules of ATP. Electrons are transferred from NADH to oxygen along 
a chain of electron carriers collectively called the electron transport chain. NADH 
dehydrogenase, the cytochrome bc1 complex and cytochrome oxidase are large 
protein complexes embedded in the inner mitochondrial membrane and 
constitute the main part of the electron transport chain. Electrons are carried from 
NADH to oxygen.  
Oxidative phosphorylation does not involve phosphorylated intermediates. In 
1961 Mitchell reported that energy liberated by electron transport is used to 
create a proton gradient across the inner membrane of the mitochondria. This 
gradient was suggested to couple electron transport and ATP synthesis. ATP 
synthase is the enzyme responsible for ATP synthesis.  
H+ ions are pumped out of the mitochondrial matrix across the inner 
mitochondrial membrane into the intermembrane space. NADH dehydrogenase, 
cytochrome bc1 complex and cytochrome oxidase are the H+ pumps that force 
the H+ ions into the intermembrane space. A higher concentration of H+ ions in 
the intermembrane space and an electrical potential, with the side of the inner 
mitochondrial membrane facing the intermembrane space being positive is 
generated by the three H+ pumps. An electrochemical proton gradient is formed. 
The protons flow back into the mitochondrial matrix through ATP synthase which 
is the driving force for ATP synthesis. Because FADH2 is reoxidised via 
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ubiquinone, its oxidation causes H+ ions to be pumped out only by the 
cytochrome bc1 complex and cytochrome oxidase and so the amount of ATP 
made from FADH2 is less than from NADH. 3 ATP molecules are synthesized for 
every NADH oxidised and 2 ATPs are made per FADH2 oxidation.     
Electron transport is normally tightly coupled to ATP synthesis. Therefore ATP is 
not synthesized unless electron transport is occurring to provide the proton 
gradient.  
1.3 Insulin Signaling 
Blood glucose levels are controlled in mammals by a hormone called insulin. 
When glucose levels in the blood are high and need to be decreased insulin is 
secreted from the β cells of the pancreas and stimulates glucose influx and 
general increase in glucose metabolism in muscle and adipocytes. Insulin also 
inhibits gluconeogenesis by the liver. Gluconeogenesis synthesizes glucose from 
non-carbohydrate predecessor and is of importance for the maintenance of blood 
glucose levels during times of starvation. The insulin receptor mediates all insulin 
signalling within the cell.  
 
1.3.1 Insulin Receptor 
The insulin receptor is a transmembrane glycoprotein with an inherent protein 
tyrosine kinase activity, which is reflected by the serum concentration of insulin. 
The insulin receptor is composed of two -subunits that are each linked to a β-
subunit. Disulfide bridges link them to each other. The -subunits are located 
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entirely outside the cell and contain the insulin binding sites, whereas the 
intracellular portion of the β-subunit contains the insulin-regulated tyrosine 
protein kinase. The insulin receptor family contains two other structurally related 
molecules, the insulin-like growth factor (IGF-1) receptor, and the insulin 
receptor-related receptor, which is an orphan receptor. These receptors share 
approximately 80% sequence homology in the kinase domain but low homology 
in the extracellular domain (Shier, et al., 1989). The external ligand-binding 
domain of the insulin receptor is linked to the tyrosine kinase by a single 
transmembrane fragment, which can adapt well to structural changes or 
substitutions (Frattali, et al., 1991). The intracellular juxtamembrane region is one 
of the several functional regions established in the β-subunit. An ATP binding 
domain, a regulatory region and the COOH terminus have also been determined. 
The juxtamembrane region has been shown to be essential for signal 
transmission (Lee, et al., 1993). Insulin binds to the insulin receptor, which 
causes the autophosphorylation of tyrosine residues and tyrosine 
phosphorylation of insulin receptor substrates such as IRS1 and Shc. This is 
mediated by the insulin receptor tyrosine kinase. Tyrosine autophosphorylation 
appears to occur through a transmembrane mechanism, in which insulin binding 
to the α-subunit of one of the αβ-dimers stimulates the phosphorylation of the 
adjacent covalently linked β-subunit (Hotamisigil, et al., 1993). The 
autophosphorylation permits the interaction of IRSs with downstream molecules 
such as PI-3K due to its Srchomology 2 (SH2) domains leading to end point 
events such as GLUT 4 translocation.   
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Signal transduction is one of the functions of the insulin receptor. Endocytosis of 
the insulin-receptor complex leads to insulin degradation. Acidification of the 
endosomal lumen due to proton pumps, results in the dissociation of insulin from 
its receptor. Most unoccupied receptors recycle to the plasma membrane, but 
after lengthily exposure and stimulation to insulin the receptor itself is degraded 
(Backer et al., 1990).   
1.4 Diabetes 
Type 2 diabetes and other associated traits such as obesity; hypertension, 
glucotoxicity and dyslipidemias have become an epic challenge for worldwide 
health care systems. An estimated $132 billion dollars was spent on the 
management of diabetic conditions and lost productivity in the year 2002 in the 
United States of America alone.  According to Hogan et al (2003) $91.8 billion 
was spent on direct medical expenditures alone. These encompassed $44.1 
billion for the excess prevalence of general medical conditions, 24.6 billion on 
chronic complications attributable to diabetes and 23.2 billion on diabetes care. 
Clearly a greater understanding for a condition reaching endemic proportions is 
merit enough for both proteomic and genetic research.  Unraveling the genetic 
causes of type 2 diabetes (T2D) will lead to the identification of new therapeutic 
targets, which will then affect the methods used to treat the disabling and life-
threatening complications of the disease.  
1.4.1 Type 2 Diabetes 
Type 2 diabetes is a heterogeneous condition of polygenic beginnings. It is the 
most common form of diabetes and involves both defective insulin secretion and 
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insulin resistance. It is a metabolic disorder that is characterized by high blood 
glucose levels. Type 2 diabetes mellitus represents a highly complex and 
heterogeneous disease that is affected by both intrinsic and extrinsic factors, 
which affect muscle metabolism and strength making it a physical disability. 
Modern lifestyles are commonly believed to play an important role in the 
establishment of type 2 diabetes due to high fat, high sugar diets paired with little 
or no exercise. Obesity-associated metabolic complications play a fundamental 
role in the development and progression of this disease. The pathophysiology of 
type 2 diabetes involves defects in tissue sensitivity to insulin and decreased 
insulin secretion. Type 2 diabetes entails progressive deterioration in β cell 
function (Porte et al., 2001, Leahy et al., 2005), associated with loss of β cell 
mass due to apoptosis (Steil et al., 2001). Type 2 diabetes patients often develop 
type 2 diabetes related complaints such as, hyperglycemia (high blood sugar), 
dyslipidemia (high levels of lipids and lipoproteins in the blood, glucotoxicity 
(describes the effect of long-term hyperglycemia on β cell function) and 
lipotoxicity, which make the disease harder to treat.   
 
1.4.1.1  Obesity 
Modern sedentary lifestyle and obesity-associated metabolic complications 
clearly play a role in the progression of type 2 diabetes. Obesity is defined as a 
BMI (body mass index) greater than 30. It is estimated that 20% of adult 
Americans are clinically obese. Free fatty acids (FFA) are known to play crucial 
physiological roles in skeletal muscle, heart, liver and pancreas. FFA 
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concentrations are commonly elevated in obese individuals. This is believed to 
be due to a increased FFA release which is associated with an expansion in fat 
mass (Jensen et al., 1989). Elevated FFAs have been shown to be a good 
predictive marker for the transition of patients from impaired glucose tolerance 
(IGT) to type 2 diabetes as FFA’s are commonly elevated in type 2 diabetes 
patients. A reduced oxidative enzyme capacity of skeletal muscle has been found 
in type 2 diabetes as well as in obesity that is not complicated by diabetes. 
Approximately 80% of people with type 2 diabetes are obese, with nearly all 
being insulin resistant (Boden et al., 2003). There is a strong relationship 
between increased plasma FFA, intramyocellular lipid accumulation and insulin 
resistance (Perseghin et al., 1997). High plasma FFA concentrations are 
associated with a number of cardiovascular risk factors linked to insulin 
resistance including hypertension (chronic high blood pressure) and 
dyslipidaemia (high levels of lipid and lipoproteins in the blood).  
 
1.4.1.2  Animal Models of Diabetes 
The Goto-Kakizaki rat inbred model was developed by Tohoku University in 1975 
by selective breeding of an outbred colony of Wistar rats. Oral glucose tolerance 
test where performed and animals with high glucose levels were selected for 
further breeding. This animal model is spontaneously diabetic and experiences 
unabating insulin signalling (Krook et al., 1997) which usually transpire by 4 
weeks of age. These animals have been well characterised and have been 
reported to experience increased blood glucose levels without adjustments in 
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non-fasting plasma insulin levels (Witte et al., 2002), a reduced employment of 
GLUT 4 the glucose transporter (Mulvey et al., 2005), abnormal mitochondrial 
functioning (Shen et al., 2008), a reduced percentage of oxidative fibres (Yasuda 
et al., 2002) and an inhibition of insulin-receptor autophosphorylation. In GK rats, 
the neonatal β cell-mass deficit is considered to be the primary defect leading to 
basal hyperglycaemia, which is detectable around 3.5 weeks of age. After 8 
weeks, hyperglycaemia deteriorates and glucose-stimulated insulin 
release by the islets is more severely impaired (Suzuki et al., 1997). Heritability 
of defective β-cell mass and its function in the GK model is thought to reflect the 
complex interactions of the following pathogenic factors: (a) three independent 
loci containing genes responsible for impaired insulin secretion; (b) heritable 
gestational metabolic (hyperglycaemic) impairment inducing deficiency in 
endocrine pancreas; and (c) secondary (acquired) loss of β−cell differentiation 
due to long-term exposure to hyperglycaemia (glucotoxicity) (Portha et al., 2003). 
Prolonged exposure to hyperglycaemia is one of Key factors in the induction of 
progressive diabetic nephropathy in humans. The same phenomenon was 
observed in GK rats.  
The Leprfa mutaion was discovered in 1961 in the 13 M outbred rat stock by Lois 
and Zucker. The Zucker rat inherited a defective leptin recepror in the 
hypothalamus and does not resist feeding or weight gain. This model has since 
been well characterized as a model of obesity showing commonly published 
metabolic symptoms including insulin resistance and hyperlipidemia. This model 
faces diminished GLUT4 protein translocation of glucose (Dokken et al., 2006, 
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Furnsinn et al., 1997), premature skeletal muscle fatigue (Frisbee et al., 2003) 
and remodeling of skeletal muscle microvasculature (Frisbee et al., 2006). I 
chose to work with GK muscle tissue because they represent a suitable model 
system for studying fundamental mechanisms of type 2 diabetes without the 
potentially complicating factors due to obesity. For the purpose of this study all 
animals where weight and age matched. The animals used in chapters 3 and 4 
where donated from UCD, and all experienced the same living conditions and all 
where fed on the same diet. The animals used in the later studies (chapters 5 
and 6) where bought from Taconic in Denmark. Taconic is a commercial supplier 
of transgenic, inbred, outbred and hybrid mice and rats and follows stringent 
breeding protocols.    
 
Figure 1.8: The Goto-Kakizaki rat spontaneously presents with the diabetic condition.   
1.4.2 Insulin Resistance 
Insulin resistance is caused by the decreased ability of peripheral target tissues 
such as muscle, to respond correctly to normal circulating concentrations of 
insulin. Ordinarily, insulin binds to the insulin receptors on the surface of the 
target cells, which triggers a cascade of cellular events, which result in glucose 
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transport and metabolism. When glucose levels in the blood increase, the level of 
insulin also increases to rectify glucose levels. However when glucose levels are 
maintained at high levels in the blood insulin levels become exhausted. So after 
a period of compensatory insulin secretion, impaired glucose tolerance 
eventually develops, despite elevated insulin levels as insulin resistance 
increases.  Insulin resistance in muscle and fat cells reduces glucose uptake, 
whereas insulin resistance in the liver results in reduced glycogen synthesis and 
therefore higher levels of glucose, which are released into the blood. Insulin 
resistance is believed to precede type 2 diabetes by up to 2 decades (Cowie, et 
al., 2009), and is often referred to as “pre-diabetes”.   
1.4.2.1  β cell dysfunction  
β cells of the pancreas are most commonly known for the secretion of the 
hormone insulin. They are found in the islets of Langerhans and make up 65-
80% of the cell population in these regions. β cells secrete insulin in response to 
an increase in blood glucose levels, and as a result play a critical role in 
maintaining glucose homeostasis. Normoglycemia or β cell compensation is how 
the body responds to increased blood glucose levels in insulin resistant states. 
When the pancreata of lean versus obese candidates were examined, it was 
seen that the obese subjects experienced an increase in β cell mass when both 
groups had not developed type 2 diabetes (Butler et al., 2003). For β cell mass 
expansion an increase in nutrient supply is important. It has been reported that 
GLP-1 enhances β cell proliferation (Jhala et al., 2003) and PKB prevents cell 
death through apoptosis via phosphorylation and inhibition of BAD which is a 
  39
proapoptotic protein (Jetton et al., 2005). It is important to note that β cell mass 
expansion does not necessarily result in β cell failure and type 2 diabetes. A 
study of β cell volume and markers for β cell proliferation and apoptosis in 
autopsy pancreata was conducted on unaffected patients and those with type 2 
diabetes. This study showed a 63% loss of islet β cell volume in obese type 2 
diabetic subjects. The study concluded that  cell mass changes are not confined 
to late-stage type 2 diabetes.   
1.5 Proteomics 
The concept of the proteome was first proposed by Wilkens and Williams in 1995 
(Wilkens et al 1995), and is defined as the PROTein expressed by a genOME 
and is the systematic analysis of protein profiles of a tissue or a biological fluid. 
Proteomics therefore is the mass screening of a system and the documentation 
of the proteins within.  
The complexity of the proteome is caused by regulated degradation, alternative 
RNA splicing and post-translational modifications (Gygi et al., 1999). There are 
more than 200 possible chemical modifications that a protein can undergo. Some 
of these modifications affect function, location and activity within the cell. Some 
of the more common modifications encountered are ubiquitination, glycosylation, 
methylation, acetylation, palmitoylation, histone modifcation and phosphorylation. 
It has become very clear to researchers that knowing the genome does not 
predict the proteins that are expressed. In other words genetic information does 
not always confer a function to a gene product and the abundance of mRNA 
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does not always correlate to the amount of protein produced (Anderson et al., 
1997). To overcome this, the total expression complement of the cell is studied. 
Expression proteomics involves the complete denaturation of proteins, destroying 
the three-dimensional structure, and using further analysis to determine 
quantitative changes in the abundance of proteins under different conditions. 
Acquiring functional information about specific proteins requires the maintenance 
of protein structure. Functional proteomics allows researchers to identify the 
purpose of the protein being studied and its role within the cell.  
1.5.1  Advantages of proteomics in disease analysis 
Differential proteomics is a treasured technique for improving the understanding 
of critical cellular biochemical reactions. Two-dimensional gel electrophoresis 
(2DGE) and the subsequent identification of proteins via mass spectrometry has 
become the main technique used by many research groups. Utilising these 
techniques has shown to be extremely informative for many diseases.  
The information obtained through these proteomic studies have lead to the 
uncovering of many new biomarkers for the specific disease studied as well as 
markers for the progression of the diseased state.  
1.5.2  Analysis of the proteome 
To establish the function of a protein the location, expression and structure of 
that protein must be determined (Pennington, 1997). Often the protein mixtures 
of interest are complex and intricate and require comparative proteomics. A good 
starting point is protein separation via 2D gel electrophoresis where complex 
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protein samples are sequentially separated by two unrelated physical properties 
to reduce sample complexity. 2DE (two-dimensional electrophoresis) is 
commonly paired with protein identification by means of mass spectrometry. 
Validation of mass spectrometry results is commonly conducted by 
immunological methods such as western blotting or immunohistochemistry. Over 
the last thirty years, two-dimensional gel electrophoresis has been at the heart of 
protein analysis as it can differentiate between different post-translational 
modified proteins, which are of significant importance to the study of disease 
(Gorg et al., 2004, Hanash, 2003), as well as discriminating between different 
isoforms of a protein. Complex protein mixtures are difficult to work with and 
require separation across two dimensions for more successful analysis of protein 
expression alterations and changes in function, location and structure. 
Separation proteins based on charge is called isoelectric focusing (IEF).  IEF 
manipulates the fact that a molecules charge will change with the pH of its 
environment. Proteins migrate under electrical currents towards their isoelectric 
point (pI), which is the point at which a protein has a net charge of zero. IEF is 
conducted under a pH gradient and is the first-dimension of the two-dimensional 
separation of proteins. The second dimension separation in based on molecular 
mass and utilises a procedure called polyacrylamide gel electrophoresis (PAGE). 
Proteins are denatured and given a negative charge via treatment with sodium 
dodecyl sulphate (SDS). The proteins being analysed are negatively charged and 
migrate toward an anode when an electrical current is applied. The 
polyacrylamide gel acts as a sieve through which the smaller proteins pass more 
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quickly.  
   
In 1975 Klose published a paper showing how an earlier method (Smithies & 
Poulik, 1956) utilised only for serum proteins, could be manipulated and modified 
for use with other more complex groups of proteins such as whole cell lysates. 
The method reported by Klose replaced the paper and starch protein separation 
method with a polyacrylamide gel. Around the same time O’Farrell reported the 
tandem use of IEF cylindrical gels and SDS-PAGE. This was the first description 
of IEF and SDS-PAGE coupled protein separation. The evolution of these two-
dimensional protein separation techniques has lead to the development of more 
reproducible immobilne pH gradients (IPG) of different and smaller pH ranges for 
first dimension separation and the development of high-resolution slab gels. 
These improvements, along with better software for image analysis and the ever 
evolving field of mass spectrometry have resulted in a technique which is up to 
date constantly developing.  
1.5.2.1  Isoelectric Focusing 
Prior to separation proteins must be lysed from within the cell without inducing 
protein modifications which may cause fictitious spots on the gel, while still 
liberating as many protein species as possible. Mechanical breakdown of muscle 
samples through pulverisation with liquid nitrogen preceding chemical lysis is the 
most effective method to release proteins from tissue samples. Different samples 
require different buffers, based purely on the solubility of the protein to be 
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recovered. One of the most popular solubilisation buffers used is that 
documented by O’Farrell (1975). Detergents such as SDS aid in the disruption of 
noncovalent protein interactions but can also interfere with IEF as this detergent 
id anionic. A zwitterionic detergent like CHAPS for example, can resolve this 
problem as it carries no charge and therefore does not interfere with IEF. Urea 
and thiourea are also commonly used in solubilisation buffers as they are 
denaturing agents which also aid in solubility of proteins. Nucleic acids cause 
mimicked migration and streaking in the second dimension as well as increasing 
sample viscosity and so are often removed from the sample. DTT or -
mercaptoethanol reduces disulfide bonds within protein structures. DTT is 
charged and migrates out of the gel during IEF. Amino acid side chains on 
proteins can carry different charges, positive, negative or zero net electrical 
charge. The proteins can be forced to the pH, which correlates with the pI by an 
electrical field.  IEF manipulates the fact that proteins net charge is determined 
by the pH of their local environments. Synthetic carrier ampholytes create a 
gradient on the IPG strip and increase the reproducibility of IEF. IPG strips 
(Amersham Pharmacia Biotech) employ eight acrylamide derivatives, which are 
attached to the polyacrylamide strip by vinyl bonds. These strips are rehydrated 
using a lysis buffer without any additional salts as salts interfere with IEF and 
protein separation. Protein samples can be applied to the IPG strips in several 
ways, for example in-gel rehydration (where the protein and rehydration buffer 
are mixed) or cup-loading (where a plastic cup is used to incorporate the protein 
on to the strip).  IEF should be performed at 200C to prevent urea re-
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crystalisation. Lower voltages at the beginning of IEF protocols allow the sample 
to be gentle introduced to the strip and higher voltages to drive the proteins to 
their correct pI. These IEF methods must be optimised for sample to sample as 
focusing times can lead to streaking and artificial spots being present on the 
resulting 2D map.     
 
1.5.2.2  Polyacrlamide gel electrophoresis 
Equilibration between the dimensions is critical as it allows the protein on the 
strip to interact with SDS. This ensures that the proteins will migrate 
appropriately during PAGE as SDS transmits a negative charge to the protein. 
DTT, as previously discussed, is a reducing agent and disrupts the disulfide 
bridges within proteins and is present in the first equilibration step. Excess or 
residual DTT causes point streaking and therefore should be removed before 
PAGE. DTT is easily removed via the second equilibration step, which contains 
iodoacetamide (IAA). IAA alkylates free DTT, removing it for the second 
dimension separation.  
Commonly polyacrylamide gels are usually 12.5% acrylamide. IPG strips are 
placed onto a large slab gel and an electrical current is applied forcing proteins to 
travel through pores in the gel. As the proteins travel through the gel smaller 
proteins travel faster than large ones and therefore smaller proteins resolved at 
the bottom of the gel and larger ones at the top as larger proteins are stunted by 
the small pore size. The resolution experienced using 2DE is dependent on the 
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size of the area available for separation. Using smaller pH ranges on large 2D 
gels increases the number of protein spots that can be separated and visualised.  
The limitations experienced during 2D can vary from the limited capacity for 
protein concentration of IPG strips and masking of proteins (more abundant 
proteins resolving at the same point as a protein of smaller abundance). Despite 
these limitations 2D electrophoresis is an ever-improving field and remains the 
method of choice for protein separation.  
1.5.2.3  Protein Visualisation 
The selection of the suitable protein detection and visualisation method is hugely 
important, as it is necessary to be able to measure changes in expression levels 
of proteins quantitatively. Two factors must be taken into account when choosing 
a stain; the sensitivity and the dynamic range of the stain (Westemeier and 
Marouga, 2005). Coomassie Blue is a commonly used protein stain. It works by 
binding to the amino groups of the proteins by electrostatic and hydrophobic 
interactions in acidic conditions. Coomassie Blue staining is highly reproducible, 
shows little to no backround and is an endpoint stain (Neuhoff et al., 1988). This 
stain however, has a limited detection range of 200-500ng/spot.  
Silver staining has a very high sensitivity of 0.1ng and is a commonly used 
technique. Silver staining has a number of drawbacks, firstly it is a multistep 
procedure but the results are available relatively quickly. It also has a low 
dynamic range and can on occasion negatively stain proteins. Silver staining is 
unsuitable for mass spectrometry and the silver particles must be removed from 
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the protein plugs prior to protein identification.  
Alternatives to these stains are fluorescent stains that are gaining in popularity 
due to a superior linear dynamic range and greater sensitivity. Some drawbacks 
of fluorescent staining include the altered mobility of pre-labelled proteins and the 
rapid decay of signal. 
1.5.2.4  Identification of proteins 
There are several methods of identifying proteins after 2D gel electrophoresis. 
Several of these can be both time consuming and costly when dealing with a 
large number of proteins, for example Western blotting or immunohistochemistry. 
Mass spectrometry is the current method of choice for the identification of 
proteins due to its high analytical sensitivity and the magnitude of protein 
identification achievable through protein databases. Protein mixtures from 
cellular lysates can be digested with trypsin into peptides (Tabb et al., 2003). 
These peptides are then separated using capillary liquid chromatography and 
electrospray interface of Electron Spray Ionisation (ESI) that fragments the 
peptides by collision induced dissociation. In ESI the analyte is in solution. From 
a spray of highly charged droplets the ions are ejected into the gas phase and 
moved into the mass analyser. A nebulising gas, usually nitrogen or helium, is 
used to stabilise the spray. To nebulise is to convert a liquid into a mist or fine 
spray.  
Large ions such as peptides are easily analysed by ESI as they are typically 
multiply charged, which brings them into the range of mass-to-charge (m/z) ratio 
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of a typical mass spectrometer. Once the m/z is determined the peptide mass 
fingerprint (PMF) is generated. The mass accuracy and the percentage of the 
protein sequence covered are analysed using state of the art highly developed 
scoring algorithms in a bid to calculate the level of confidence for the match 
(Berndt., et al 1999). When high mass accuracy is achieved, as a rule at least 
two peptide sequences must be matched to the sequence of the protein 
suggested and 10-15% of the sequence must be covered for an unambiguous 
identification. When PMF is used for the identification of protein species, the 
organism from which the sample was generated must have its genome 
completely sequenced. This method of protein identification can identify 50-90% 
of proteins analysed when at least a few hundred femtomole of gel-separated 
protein is present (Mann et al., 2001)    
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 Figure 1.9: Two-dimensional electrophoresis separation of proteins. To compare the proteome of 
cells treated with two conditions, first the proteins must be solubilized using various chemicals 
designed to lyse proteins from within the cell. The protein lysate can then be separated first 
based on the pI and then based on molecular weight (MW). This creates a 2D map of the 
proteins. The proteins are then visualized using various staining methods and then these maps 
are compared using software which matches protein spot patterns between gels and then 
compare the abundance of the proteins. Any proteins which have changes in abundances can 
then be excised from the gels and enzymatically digested in order to identify the protein in 
question using mass spectrometry techniques. 
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1.5.3 Immunoblotting 
It is important to validate and confirm mass spectrometry data through a different 
method. Some popular techniques are immunoblotting (Towbin et al., 1979) and 
immunofluorescence  microscopy. Western blotting can detect the abundance of 
one protein within a complex protein mixture. The technique takes advantage of 
the specificity of antibodies to detect a protein of interest. After SDS PAGE 
negatively charged proteins are transferred to a nitrocellulose or polyvinylidene 
fluoride (PVDF) membrane via an electrical current. The membranes which now 
have protein bound to them, are blocked with milk proteins to limit non-specific 
binding of the antibody to be used.  The protein of interest is detected by treating 
the membrane with an antibody specific for the protein and then treating the 
membrane with a secondary antibody which is species specific to the primary 
antibody. Conjugated to the secondary antibody is the enzyme horseradish 
peroxidise which cleaves the chemiluminescent substrate to produce light. X-ray 
film exposed to the light generated results in a quantifiable banding pattern that 
can be used to establish protein abundance.      
1.5.4 Experimental Design 
 
When studying any condition one must take into consideration the affected 
population. From this population many or few affected may arise. Depending on 
the incidence of the condition one must also devise a manageable number of test 
subjects. In most incidences human test subjects are not used due to large 
variances in lifestyle such as diet and environment. The Wistar rat has proven to 
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be a reliable and reproducible model for human conditions such as ageing 
(Doran et al., 2005) and as a control for many more (Mulvey et al., 2007). The 
design of an experiment is crucial to the statistical relevance of the results. 
Obviously cultivated rat specimen populations are much smaller than that of the 
human condition it mirrors and as a result smaller test groupings are used 
depending on the sample numbers available. At this point one must consider 
replicates. Replicates by definition mean to duplicate, copy, reproduce, or repeat. 
Biological replicates are animals which present with the same condition and have 
experienced similar if not the same living conditions. Biological variation occurs 
from animal to animal even when possible variables are reduced to a minimum 
and can be substantial or subtle. Depending on the number of biological 
replicates available for experimentation one must also consider technical 
replicates. When regarding experimental data a technical replicate can be either 
a replicate from the same animal within a population or another individual animal 
for which the population number is big enough for it to be statistically significant 
independently. As previously discussed by Karp et al (2007) depending on the 
available resources to the experiment, technical replicates generated from the 
same animal are hard to avoid and biological repeats provide more statistically 
sound scientific information.  From this the power of an experiment can be 
deduced (Karp et al., 2007). The power can be calculated for each individual or 
for the entire experiment. The power of an experiment is the probability that an 
effect will be detected. Another common concern arises when interests do not lie 
with diagnostics only but biomarker studies. The issue of pooling sample has 
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always been controversial and yet unavoidable for some. Pooling of samples can 
lead to a reduced biological variance seen throughout an experiment and can 
also hamper the statistical relevance of the data recovered from such an 
experiment (Karp et al., 2007).   
 
1.5.5 Image analysis  
Thousands of individual proteins can potentially be visualised on a large two-
dimensional gel.  The maps generated from 2D PAGE must be analysed to 
highlight spots and therefore proteins of interesting abundance alterations. To 
compare high-resolution 2D gels sensitive densitometric software had been 
developed like Progenesis SameSpot software (Non-Linear), Image Master 
(Amersham Biosciences), Impressionist (Gene Data) and DeCyder (GE 
Healthcare) which is specifically designed to manipulate DIGE experiments. The 
software maps the gel images to each other creating vectors from the correlating 
spots on one gel to that on another while removing noise and artefacts. Detection 
and quantification of the spots present on all gels ensues with the normalised 
volumes of all matched spots being calculated. The normalised volumes are 
compared to generate abundance changes across biological and technical 
replicates. The softwares available all require the user to establish backround 
threshold and statistical cut offs.    
1.5.6 Aims of the project 
The aim of this project was to study type 2 diabetes without the complications 
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associated with obesity. In an attempt to further understand the disease 
proteomic techniques where employed to analyse skeletal muscle tissue from a 
non-obese animal model, the Goto-Kakizaki rat. We proposed that proteomic 
analysis of skeletal tissue from the non-obese animal model would yield a greater 
understanding of the mechanisms by which glucose metabolism in affected in 
type 2 diabetes. By the use of proteomic techniques, the identity of several 
potential biomarkers for altered glucose, fatty acid and amino acid metabolism 
were uncovered as well as proteins affecting the contractile apparatus and 
cellular stress response.  
The analysis of the mitochondria was of key importance to this primarily 
metabolic condition. The analysis of the mitochondrial proteome was undertaken 
to highlight any changes in its role in apoptosis, metabolism and free radical 
production. This enrichment yielded a great deal of data, some of which 
highlighted the fundamental role of the mitochondria in normal muscle 
homeostasis.  
Hydrophobic protein enrichment using a detergent phase separation technique 
was also employed in a bid to highlight potential defects in the membrane 
proteins associated with glucose uptake and insulin receptor signalling. 
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2 Materials and Methods  
 
2.1 Materials 
 
2.1.1 General chemicals and reagents 
 
General chemicals and reagents were purchased from Sigma Chemical 
Company (Dorset, UK) and were of reagent/electrophoresis grade, unless 
otherwise stated. Distilled H2Owas purified using a Millipore Milli-Q apparatus to 
obtain milli-Q water (mQH2O). Complete Mini tablets containing Protease 
inhibitors were purchased from Roche Diagnostics and Bradford reagent from 
BioRad. 
2.1.2 1-D and 2-D electrophoresis 
 
Acrylamide stock solutions were obtained as Ultrapure Protogel (30% (w/v) 
Acrylamide: 0.8% (w/v) bis Acrylamide (37.5:1)) from Natural Diagnostics 
(Atlanta, GA, USA). Isoelectric focusing pH Gradient (IPG) drystrips for 2-d 
electrophoresis, ampholytes and cover fluid were purchased from Amersham 
Biosciences/GE Healthcare (Little Chalfont, Bucks, UK). All protein molecular 
weight markers were purchased from New England Biolabs (Herts, UK). 
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 2.1.3 Protein Visualization  
 
PhastGel Coomassie Blue R-350 tablets, Coomassie Blue G-250 and PlusOne 
Silver Stain Kit were purchased from Amersham Bioscience/GE Healthcare (Little 
Chalfont, Bucks, UK).  RuBPs (Ruthenium 2 Bathophenanthroline Disulfonate 
Chelate 20mM stock solution) was synthesised in lab. Potassium pentachoro 
aquo ruthenate, bathophenanthroline disulfonate and sodium ascorbate were 
purchased from Sigma Chemical Company (Dorset, U.K.). 
2.1.4 Mass Spectrometry 
 
Acetonirtile was obtained from Amersham Biosciences/GE Healthcare (Little 
Chalfont, Bucks, UK). Sequence grade-modified trypsin was purchased from 
Promega (Madison, WI, USA). Formic Acid and LC/MS Chromasolv water were 
from Fluka (Dorset, UK) 
2.1.5 Western Blotting 
 
Nitrocellulose membrane was obtained from Millipore (Bedford, MA, USA). 
Chemiluminescence substrate was purchased from Pierce and Warriner 
(Chester, UK). X-ray film was purchased from Fuji Photo Film Co. Ltd. (Tokyo, 
Japan). GBX Developer/Replenisher, GBX Fixer and Replenisher and Ponceau 
S-Red Staining Solution were obtained from Sigma Chemical Company (Dorset, 
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UK). All commercially available antibodies used in this research were purchased 
from the companies detailed in Table 2.1. List of antibodies used for this project 
including the appropriate dilutions for both the primary and secondary antibodies, 
host species can be seen in Table 2.2.  
 
 
 
Table 2.1: Antibody Suppliers 
Company Address 
Abcam Abcam Plc (Cambridge, Uk) 
ABR Affinity Bioreagents (Golden, CO., 
USA) 
Abgent San Diego, CA, USA 
Calbio Calbiochem (San Diego, CA., USA) 
Chemicon Chemicon International (Temecula, 
CA., USA) 
Sigma Sigma Chemical Company (Poole, 
Dorset, Uk) 
Upstate Upstate Biotechnology (Lake Placid, 
NY., USA) 
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Table 2.2 Antibodies 
List of antibodies used for this project including the appropriate dilutions for both 
primary and secondary antibodies. 1o= primary, 2o= secondary, Species = host 
species. 
Antibody 1o Ab 
dilution 
2o Ab 
dilution 
Species Company 
1s DHPR 1:1000 1:1000 Mus ABR 
F1 ATPase 1:1000 1:1000 Mus Abcam 
Malate 
dehydrogenase 
1:500 1:1000 Shp Abcam 
Mitofilin 1:1000 1:1000 Rb Abcam 
Myosin fast 1:1000 1:1000 Mus Sigma 
NADH 
dehydrogenase 
1:500 1:500 Rb Abcam 
Na+/K+ ATPase 1:1000 1:1000 Mus Abcam 
Phosphoglycerate 
kinase 1 
1:1000 1:1000 Rb Abgent 
Prohibitin 1:500 1:500 Rb Abcam 
Pyruvate kinase 1 1:500 1:500 Gt Abcam 
SDHA 1:1000 1:1000 Gt Abcam 
SERCA 1 1:1000 1:1000 Mus ABR 
VDAC1 1:500 1:500 Mus Abcam 
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2.1.6 Immunofluorescence Microscopy  
 
OCTTTM Compound was purchased from Sakura Finetek Europe B.V 
(Zoeterwoude, Netherlands). DAPi and Liquid Blocker Super PAP Pen were 
obtained from Sigma Chemical Company (Dorset, UK). Florescent secondary 
antibodies (Goat Anti-Rabbit IgG, Goat anti-Rat, Goat anti-Mouse) were from 
Molecular Probes (Eugene, Oregon, USA). Superfrost Plus positively-charged 
microscope slides were from Menzel Glasser (Braunschweig, Germany). PPD-
glycerol was obtained from CITIFLUOT Limited (London, UK). 
 
 
2.2 Methods 
2.2.1  Animals and Dissections 
 
An out-bred strain of albino Wistar rat was used as a control model. Wistar rats 
are a strain of rats belonging to the species Rattus norvegicus. These rats are 
the first rat strain specifically developed for use in biological and medical 
research. The Wistar rat is characterised by its wide head, long ears and they 
also have a tail length that is less than its body length. The non-obese, 
spontaneous Type 2 Diabetic Goto-Kakizaki rat was used as the diseased model. 
The Goto-Kakizaki rat is a non-obese Wistar substrain which develops Type 2 
diabetes mellitus early in life. Goto and Kakizaki at Tohoku University, Sendai, 
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Japan developed the model in 1975. This animal also develops mild 
hyperglycemia, is insulin resistant and presents with hyperinsulinemia. 
The gastrocnemius muscles were dissected, snap frozen in liquid nitrogen and 
stored at -700C.  Control and diseased animals were kept at a standard light-dark 
cycle fed at libidum, were obtained from the Biomedical Facility of the National 
University of Ireland, Dublin. Rats had been originally purchased from M & B 
Taconic Ltd. Animal suppliers (Ry, Denmark). 
 
2.2.2 Extraction of total muscle protein complement for 1-D gel 
electrophoresis 
Muscle specimens were kept frozen in liquid nitrogen while being ground into a 
fine powder using a mortar and pestle. Equal quantities of 250 mg wet weight of 
muscle were used for both diseased and control samples. The resulting powder 
was placed into 1 ml of homogenisation buffer (0.5 M(N-
[2hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid]) HEPES, 200mM ethylene 
glyolbis(-aminoethyl ether)- N, N,N’,N’- tetraacetic acid (EGTA), 10% (w/v) 
sucrose, 3mM Mg2+ and a 0.1%(w/v) NaN3. To remove DNA, 2l of DNAase-1 
(200) units were added per 100l of lysis buffer. The buffer was also 
supplemented with 5 complete mini tablets, which were added to every 50mls of 
homogenisation buffer. The complete mini tablets supplement the 
homogenisation buffer with a protease inhibitor cocktail containing 1 M 
leupeptin, 1.4M pepstatin, 0.15 M aprotinin, 0.5 M soybean trypsin inhibitor, 
0.2 mM prefabloc, 0.3 M E-65 and 1mM ethylenediaminetetraacetic acid 
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(EDTA). The samples were then incubated on ice with vortexing every 10 
minutes for 10 seconds, for two and a half hours. The suspension was the 
centrifuged for 20 minutes at 20,000 g in an Eppendorf 5417 R centrifuge 
(Eppendorf, Hamburg, Germany), after which protein quantification was 
conducted as described in Section 2.2.5. Samples were then reduced with an 
equal volume of reducing buffer (0.05 M Tris, 3% (w/v) sodium-dodecyl-sulfate 
(SDS), 75 mM DTT 0.05% (w/v) bromophenol blue, 20% (w/v) sucrose) at 1000C 
for 5 minutes. The samples were then either run on a 1-D gel or aliquoted and 
stored at -700C for future use. 
 
2.2.3 Extraction of total muscle protein complement for 2-D 
electrophoresis 
As described in Section 2.2.2, the specimens were ground into a fine powder but 
were resuspended in 1 ml of lysis buffer (7 M urea, 2M thiourea, 65 mM (3-[(3-
Cholamidopropyl)-Dimethylammonio]-1-Propane sulfonate) (CHAPS), 100 mM 
dithiothretiol (DTT) and 5% (v/v) ampholytes, 5 tablets/50ml of buffer Mini 
Complete). To remove DNA, 2l of DNAase-1 (200 units) were added per 100l 
of lysis buffer. The buffer was also supplemented with 5 complete mini tablets, 
which were added to every 50ml of homogenisation buffer. The complete mini 
tablets supplement the homogenisation buffer with a protease inhibitor cocktail 
as described above in section 2.2.2. Samples were incubated at room 
temperature for two and a half hours on a shaker with vortexing for 10 seconds at 
regular intervals. The suspension was then spun at 20,000g for twenty minutes 
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using an Eppendorf 5417 R centrifuge (Eppendorf, Hamburg, Germany). The 
resulting pellet was discarded with only the lower layer of supernatant being 
retained and stored at -70oC and protein concentration was ascertained by a 
Bradford Assay. 
2.2.4 Preparation of Mitochondria-Enriched Fraction 
Three grams of gastrocnemius muscle tissue was cut into small pieces and 
homogenised in 20 ml of homogenisation buffer (220mM mannitol, 70mM 
sucrose, 2mM Hepes, pH 7.4 supplemented with 1 PIC complete mini tablet per 
10 ml (Roche Diagnostics). The resulting mixture was centrifuged at 1100 x g for 
5 minutes at 4 oC. The supernatant was retained. The pellet was resuspended in 
10 ml of homogenisation buffer (HB) and centrifuged as before. Again the 
supernatant was retained and the pellet resuspended in 5 ml of HB. The 
supernatants from all of the above steps were pooled and centrifuged at 7000 x g 
for 15 minutes. The resulting pellet was resuspended in HB and centrifuged at 
20,000 x g for 15 minutes. This was repeated three times with the pellet retained 
each time. After the final spin the pellet was resuspended in either 500 ml of 
homogenisation buffer for western blotting or 2D lysis buffer. Samples for DIGE 
were pH 8.5. The protein content was of the samples was determined via 
Bradford Assay. 
 
2.2.5 Preparation of Hydrophobic Protein Enriched Fraction. 
Rat gastrocnemius tissue samples (250mg) were ground into a fine powder 
under liquid nitrogen using a pestle and mortar. The ground tissue was 
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immediately added to 8ml of cold PBS and 2 ml of 10% Triton X-114 and left 
overnight at 40C on a rotary shaker. The suspended sample was spun at 20,000 
x g for 30 min at 40C to remove tissue debris. The supernatant was placed at 
370C for 30 min followed by a 5000 x g centrifuge spin for 30 min at 250C to 
separate the detergent (DT) and aqueous phases (AQ). The AQ top later was 
removed to a fresh 50 ml tube to which 2 ml of 10% Triton X-114 was added. The 
bottom DT phase was resuspended in 8ml of cold PBS. Both samples were 
placed at 370C for 15 min followed by a 15 min centrifuge spin at 5000xg at 250C. 
This process was repeated 3 times in order to wash each phase and remove 
contaminants. Protein was extracted from each phase by acetone precipitation at 
-200Cfor 1 hr. Following a 30 min spin at 5000xg precipitated protein extracts 
were resuspended in 1ml (AQ) and 200ml (DT) of lysis buffer.  
2.2.6 Acetone Precipitation 
 
Adding three volumes of 100% ice cold acetone to the sample and vortexing 
briefly, the mixtue was then incubated for one hour at -700C first precipitated 
samples. The sample was spun for 15 minutes at 12,000g in an Eppendorf 5417 
R centrifuge (Eppendorf, Hamburg, Germany) and the supernatant was 
discarderd. The pellet was then resuspended in three times the volume of the 
original sample of 80% ice cold acetone and left at 700C for ten minutes, the 
procedure was repeated twice before the sample was resuspended in the original 
volume of lysis buffer (Section 2.2.3) aided by vortexing or sonication with a 
Sonoplus HD2200, Bandelin (Berlin, Germany). 
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2.2.7 Protein Quantification via Bradford Assay 
 
Quantification of sample protein concentration was ascertained according to the 
method of Bradford (1976).  A standard curve was prepared by diluting a stock 
solution of 5 mg/ml BSA with sample buffer in the range 0-100 mgs. Standard 
were diluted with sample buffer, 80 ml milliQ water, and 10 ml 0.1 M HCl. 10 ml 
of sample was also diluted with 80 ml milliQ water, and 10 ml 0.1 M HCl. To both 
samples and standards 3.5 mls of working Bradford reagent (1 part Bradford 
reagent dye to 3 parts distilled water) was added, inverted and incubated for 5 
minutes at room temperature in the dark. Absorbance was then read for the 
standards and samples at 595 nm and protein concentration were then obtained 
by comparing the unknown samples to the standard curve (Bradford 1976).   
 
2.2.8 1-D gel electrophoresis 
One-dimensional SDS polyacrylamide gel electrophoresis was performed 
according to Laemmli (1970), using a Bio-Rad Mini-Protean 3 gel system (Bio-
Rad Labs., Hemel-Hempstead, Herts., UK). 5% resolving gel was made of 5% 
(w/v) acrylamide from a 30% acrylamide/bisacrylamide (37:5:1) mixture, 0.303 M 
Tris-PO4 pH 8.8, 0.438 M SDS, 0.69 M APS and 0.1% (v/v) N,N,N’,N’-
tetramethylethylenediamine (TEMED). 10% resolving gels were made of 10% 
(w/v) acrylamide, 0.303 M Tris-PO4 pH 8.8, 0.438 M SDS, 0.69 M APS and 0.1% 
(v/v) TEMED.  These two mixtures were used to create a 5-10% gradient gel. 
The stacking gel was made of 5% (w/v) acrylamide, 0.5 M Tris-PO4 pH 6.7, 0.438 
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M SDS, 0.69 M APS and 0.1 % (v/v) TEMED and was layered over the resolving 
gel. 15-100μg protein solution (Solution 2.2.2), was loaded per well. 
Electrophoesis was carried out using running buffer (0.0125 M Tris, 0.96 M 
Glycine, 0.1% (w/v) SDS). Post electrophoresis gels were either fixed for staining 
or blotting.  
2.2.9 2-D gel electrophoresis 
For Isoelectric focusing, IPG strips were rehydrated for 12 hours with rehydration 
buffer (7 M urea, 2 M thiourea, 65mM CHAPS, 100 mM DTT and 5% (v/v) 
ampholytes; containing 0.05% (w/v) bromophenol blue as tracking dye) in a re-
swelling tray from Amersham Biosciences/GE Healthcare (Little Chalfont, Bucks., 
UK).  
Table 2.3: Volume of rehydration buffer required based on strip length for 
isoelectric focusing. 
Strip Length (cm) Volume (l) 
7 125 
11 200 
13 250 
18 350 
24 450 
 
After re-swelling, the IPGstrips were loaded gel side up in an Amersham Ettan 
IPGphor manifold and covered with 108 ml of cover fluid. An appropriate amount 
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of sample was added to the strips either by anodic cup loading or in-gel 
rehydration, and run on an Amersham IPGphor IEF system, employing pH range 
specific running conditions (Table 2.4). 
Table 2.4: IEF focusing protocols 
pH range 3-10 pH range 4-7 pH range 6-11 
3500V  21hrs 3500V  21hrs 80V  4hrs 
8000V  10min 8000V  10min 100V 2hrs 
8000V  3hrs 8000V  3hrs 500V  2hrs 
    1000V  1hrs 
    2000V  1hrs 
    4000V  1hrs 
    6000V  2hrs 
    8000V  2.5hrs 
 
 
 
Following isoelectric focusing, IPG strips were equliberated twice for 20 minutes 
using 6 M urea, 30% (w/v) glycerol, 2% (w/v) SDS, 100mM Tris-HCl, pH 8.8, 
whereby the first incubation step was performed with the addition of 100mM DTT 
and the second incubation step with 0.25 M iodoacetamide. The strips were then 
briefly washed in SDS running buffer (0.0125 M Tris, 0.96 M glycine, 0.1% (w/v) 
SDS) and placed on top of a 12.5% (w/v) SDS resolving gels and set using a 1% 
(w/v) agarose sealing gel. The gel electrophoretic separation of the Type 2 
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Diabetic skeletal muscle proteome in the second dimension was carried out by 
standard SDS-PAGE using an Amersham Ettan DALT-Twelve system (Doran et 
al., 2006). Gels were electrophoresed at 1.5 W overnight until the bromophenol 
blue dye front had ran off the gel.  
2.2.10 Protein Staining 
2.2.10.1 DIGE Labelling 
Cy3 and Cy5 DIGE dyes were reconstituted as a stock solution of 1mM in fresh 
DMF (Dimethylformamide). The stock solution was diluted to a working solution 
of 0.2mM prior to labelling, and was used within two weeks. 50 mg of sample for 
each biological replicate was minimally labelled with 200 pmols of Cy3 working 
solution. A pooled sample consisting of equal quantities of protein from all 
replicates used in the experiment were labelled at 200 pmol of Cy5 working 
solution to 50 mg of protein. The pool generated was used as an internal 
standard. All samples at pH 8.5 were labelled with the appropriate amount of dye 
and after brief vortex, incubated on ice in the dark for 30 minutes. The reaction 
was quenched by adding an equal volume of lysine as dye and incubating the 
dye:protein mixture for 10 minutes on ice in the dark. Samples where loaded onto 
IPG strips with an equal volume of 2x sample buffer (7M urea, 2M thiourea, 
65mM CHAPS, 2% ampholytes and 2% DTT) during rehydration, or where frozen 
at -800C for future use.    
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 2.2.10.2 Colloidal Coomassie Staining 
Colloidal Coomassie staining was carried out according to the procedure of 
Neuhoff (et al.,1988). After electrophoresis gels were washed twice with dH2O 
and placed into colloidal coomassie staining solution, (1 part Stock Solution A 
(5% (w/v) coomassie brilliant blue G-250); 40 parts Stock Solution B (10% (w/v) 
ammonium sulphate, 2% (v/v) phosphoric acid); 10 parts methanol), overnight. 
The gels were then washed with neutralisation buffer (0.1 M Tris-PO4 adjusted to 
pH 6.5) for 1-3 minutes. The bakround was reduced by a one minute wash in 
destain (25% methanol) and the dye was fixed by an overnight wash in fixation 
solution (20% (w/v) ammonium sulphate). This procedure was repeated a 
minimium of three times or until sufficient visualisation of protein was achieved.  
 
2.2.10.3 Hot Coomassie Staining 
The staining solution (0.025% (w/v) PhastGel Coomassie Blue R-350 tablet and 
10% (v/v) acetic acid) was heated to 900C and poured over the gels to be 
stained. The gel was then placed on a laboratory shaker for 10 minutes for mini 
gels and one hour for larger gels, at room temperature. Gels were destained in a 
10% (v/v) acetic acid solution with slow agitation. Excess coomassie dye was 
soaked up with filter paper. Gels were processed immediately for mass 
spectrometric analysis or stored in a 1% (v/v) acetic acid solution. The gels were 
the scanned using a Umax Image scanner from Amersham Biosciences/GE 
Healthcare (Little Chalfont, Bucks., UK) and spots cut and processed for LC/MS 
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analysis.  
2.2.10.4 Silver Staining 
After electrophoresis, the gels were placed into fixing solution (30% ethanol, 10% 
acetic acid) for a minimum of 30 minutes. The gels were then rinsed in 20% 
ethanol twice for 10 minutes, which was followed by two 10-minute washes in 
milli-Q dH2O. Sensitising solution (0.8mM sodium thiosulfate) was poured onto 
the gels for one minute after which the gels were once again washed in milli-Q 
dH2O twice for 2 minutes. The staining solution (12 mM silver nitrate) was then 
left on the gels for 20 minutes to 2 hours. After the staining solution was removed 
and gels were washed in milli-Q dH2O for 10 seconds the developing solution 
(3% sodium potassium carbonate, 250 ml formalin, 125 ml 10 % sodium 
thiosulphate) was added to the gel. Once the protein map was visualised the gel 
was placed into stopping solution (40g Tris, 2% acetic acid) for storing. 
 
2.2.10.5 RuBP’s Staining 
Following overnight in fix solution (30% ethanol, 10% acetic acid), slab gels were 
then washed 3 times with 20% ethanol for 30 minutes. The gels were stained for 
6 h in 20% (v/v) ethanol containing 200 nM of the ruthenium chelate. The gels 
were re-equilibrated twice for 10 minutes in distilled water prior to imaging.   
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 2.2.10.5.1 Preparation of Ruthenium 2 Bathophenathroline Disulfonate 
Chelate 20mM stock solution 
Potassium pentachloro aquo ruthinate (0.2g) was dissolved in 20 ml boiling water 
and kept under reflux (deep red brown solution). Bathophenanthroline disulfonate 
(3M) (0.9g) was then added and the reflux was continued for 20 min (greenish-
brown solution). Sodium ascorbate solution (500 mM) (5ml) was added and the 
reflux was continued for 20 minutes (deep orange-brown). The solution was 
allowed to cool and then adjusted to pH7 with sodium hydroxide. The volume 
was adjusted to 26 ml and was stored at 4oC (several months).  
2.2.11 ESI LC/MS 
2.2.11.1 Sample preparation for mass spectrometry 
The gel was first washed with deionised water (2 x 10 min) and the Coomassie 
Blue-stained spots of interest were excised from the gels and placed into 
siliconised 1.5 ml Eppendorf tubes. The gel plugs were then destained, desalted 
and washed as follows: Gel plugs were first washed with water and then with 
50mM NH4HC3/acetonitrile 1:1 (v/v) for 15 min at 370C. The liquid was removed 
and the enough acetonitrile was added to cover the gel plugs. Acetonitrile was 
removed and the gel plugs were rehydrated in 50mM NH4HCO3.  After 5 min, an 
equal volume of acetonitrile was added. After 15 min of incubation all the liquid 
was removed and the gel plugs were then dehydrated in 100% acetonitrile. The 
acetonitrile was removed and, the gel plugs were then dried down for 30 min 
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using a Heto type vacuum centrifuge from Jouan Nordic A/S (Allerod Denmark). 
Individual gel plugs were then rehydrated in enough digestion buffer (1mg of 
trypsin in 20ml of 50mM NH4HCO3) to cover the gel plugs. More digestion buffer 
was added if all the initial volume had been absorbed by the gel pieces. The 
samples were then incubated at 370C 4 hr – over night. The peptides generated 
by tryptic digestion were recovered by removing supernatants from the digested 
gel plugs. Further recovery was achieved by adding 30% acetonitrile/ 0.2% 
trifluroacetic acid to the gel plugs for 10 min at 370C with gentle agitation. The 
resulting supernatants were added to the initial peptide recovery following trypsin 
digestion. Exhaustive peptide recovery was achieved through the addition of 60% 
acetonitrile/0.2% trifluotoacetic acid to each plug for 10 min at 370C with gentle 
agitation. Supernatants were added to the peptide pool and the sample volume 
was reduced until dry through vacuum centrifugation. Samples were 
resuspended in 15ml of ultrapure ddH2O and 0.1% formic acid for identification 
by ion trap LC/MS (Liquid Chromatography/ Mass Spectrometry) analysis. 
2.2.11.2 Ion Trap Mass Spectrometry 
 
The mass spectrometric analysis of peptides was carried out in the Proteomics 
Suite of the National University of Ireland, Maynooth with a Model 6340 Ion Trap 
LC/MS apparatus from Agilent Technologies (Santa Clara, CA). Excision, 
washing, destaining and treatment with trypsin, was performed by the above 
optimised method. Separation of peptides was performed with a nanoflow Agilent 
1200 series system, equipped with a Zorbax 300SB C18 5mm, 4mm, 40 nl 
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precolumn and a Zorbax 300SB C18 5 mm, 43mm x 75mm analytical reversed 
phase column using HPLC-Chip technology (Staples et al., 2009). The mobile 
phases utilised were A: 0.1% formic acid, B: 50% acetonitrile and 0.1% formic 
acid. Samples (5ml) were loaded into the enrichment column st a capillary flow 
rate set to 4ml/min with a mix of A and B at a ratio 19:1 (v/v).Tryptic peptides 
were eluted with a linear gradient of 10-90% solvent B over 15 min with a 
constant nano pump flow rate of 0.60ml/min. A 1min post time of solvent A was 
used to remove sample carry over. The capillary voltage was set to 2000 V and 
the flow and the temperature of the drying gas was 4ml/min and 3000C, 
respectively. For protein identification, database searches were carried out with 
Mascot MS/MS Ion search (Matrix Science, London, UK). All searches used 
‘Rattus norvegicus’ as taxonomic category and the following parameters: (i) two 
missed cleavages by trypsin, (ii) mass tolerance of precursor ion 2.5 Da and 
product ions 0.7 Da, (iii) carboxymethylated cystines fixed modification, and (iv) 
oxidation of methionine as variable modification. In addition, the percentage of 
coverage was set at over 10%, with at least 2 matched distinct peptides. 
Importantly, all pI-values and molecular masses of identified proteins were 
compared to the relative position of their corresponding two-dimensional spots on 
analytical slab gels. 
2.2.12 Immunoblotting  
Electrophoretic transfer of proteins to Immobilin NC-pure nitrocellulose 
membranes was carried out according to Towbin et al., (1979) using a Bio-Rad 
Mini-Protean II transfer system (Bio-Rad Labs., Hemel-Hempstead, Herts., U.K.). 
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Proteins were transferred for one hour at 100V and at 4oC. Efficiency of transfer 
was evaluated by Ponceau-S-Red staining of membranes, followed by de-
staining in phosphate buffered saline (PBS) (50mM sodium phosphate, 0.9% 
(w/v) NaCl, pH 7.4). Membranes were blocked for 1 h in 5% (w/v) fat-free milk 
powder in PBS. Membranes were then incubated for three hours at room 
temperature or overnight at 4oC with primary antibody, appropriately diluted with 
blocking buffer (refer to Table 2.3 for primary and secondary antibody dilutions). 
Nitrocellulose blots were subsequently washed (2 x 10min) in blocking solution 
and then incubated with an appropriate dilution of the corresponding peroxidase-
conjugated sondary antibody (anti-mouse and anti-rabbit secondary antibodies 
for monoclonal and polyclonal primary antibodies, respectively), for one hour at 
room temperature. The nitrocellulose membranes were then washed extensively 
(2x10min) in blocking solution and rinsed (2x10min) with PBS. Immunoreactive 
were visualized using SuperSignal® Enhanced Chemiluminesence substrate 
luminol/enhancer (Pierce and Warriner, Chester, Cheshire, U.K.), for the 
detection of horseradish peroxidase in Western blotting. Densitometric scanning 
of immunoblots was performed on a Molecular Dynamics 300S computing 
densitometer (Sunnyvale, CA, USA) with Imagequant V3.0 software. Statistical 
analysis of densitometry results from immunoblots was carried out using 
Graphpad prism statistical software (Graphpad software Inc.). p<0.05 is 
significant. 
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3 Proteomic profiling of non-obese type 2 diabetic 
skeletal muscle 
3.1 Introduction 
Abnormal glucose handling has emerged as a major clinical problem for millions 
of diabetic patients worldwide. The number of diabetic patients suffering from 
severe metabolic disturbances and glucotoxic complications is rapidly increasing 
and the incidence of diabetes is fast approaching endemic proportions (King et 
al., 1998). Type 2 diabetes mellitus represents a highly complex and 
heterogeneous disease that is influenced by both genetic and environmental 
factors (Luna et al. 2005).  A modern inactive lifestyle coupled with obesity-
associated metabolic complications play an essential role in disease 
development and progression. An abnormal sensitivity of peripheral tissues to 
insulin and decreased levels of hormone secretion are the typical and foremost 
characteristics of T2D. Since contractile fibres are responsible for most of the 
insulin-stimulated whole body glucose disposal, skeletal muscle tissues are 
particularly affected by insulin resistance, and as a result impaired insulin 
signalling and disturbed glucose metabolism in muscle tissues becomes a 
prominent aspect of T2D (Peterson, et al.,2002). 
There is a limited understanding as to how abnormal tissue sensitivity to insulin 
causes decreased skeletal muscle strength (Andersen, et al., 2004), especially in 
older patients (Park, 2006). Fatty acid metabolism has an overwhelming 
influence on diabetic side effects.  As outlined by Phielix and Mensink (2008), 
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impaired insulin-mediated glucose uptake is not the only trait that stands out in 
the diabetic condition. High levels of circulating free fatty acids, diminished 
mitochondrial functioning and an overall weakened metabolic adaptability in the 
skeletal muscle tissues aid in the development of some of the more common 
type 2 diabetes associated conditions such as inhibited insulin signalling and 
insulin resistance.  
In order to further our molecular understanding of diabetes-related abnormalities 
in skeletal muscles, mass spectrometry based proteomics nominates itself as an 
ideal analytical tool for performing global screening approaches to determine 
potential alterations in protein expression levels (Korc, et al., 2003). Proteins are 
the biological effector molecules of the cell. Proteomics is the large-scale and 
high throughput biochemical approach to study entire protein complements (De 
Hoog and Mann, 2004), which are qualities appropriate for the global 
identification of complex alterations in diabetic tissues. Sundsten and Ortsaeter 
(2009) recently discussed how numerous proteomics projects have been 
instigated to disentangle complex pathobiochemical mechanisms that underlie 
diabetes. Many of these studies have focused on the pancreas, blood, adipose 
tissue and the liver for reasons such as highlighting the underlying dysfunction of 
b cells in the pancreas and studying protein patterns in organs involved in 
glucose homeostasis such as the liver and adipose tissue. Deduction of altered 
protein expression patterns during the aging process may lead to the discovery 
of new therapeutic targets as well as protein biomarkers for disease progression 
of the diabetic condition.   
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In this study, we carried out the proteomic profiling of crude skeletal muscle 
extracts from the Goto-Kakizaki (GK) rat model of type2 diabetes (Kitahara et al. 
1978). The animal model has been a staple in investigating muscular disorders 
over the past few decades. Skeletal muscle specimens from inbred animal 
strains exhibit genetically much less inter-individual differences as compared to 
patient biopsies, and therefore considerably lower experimental repeats are 
required in initial proteomic profiling experiments. As a result cohorts of new 
biomarkers identified by animal model proteomics can then be used for an in-
depth characterisation of diseased human muscle in order to improve diagnostic 
procedures or design better treatment strategies. GK rats are spontaneously 
diabetic animals that exhibit chronically impaired insulin signalling (Abdel-Halim 
et al,. 1994, Krook et al., 1997), which usually occurs by 4 weeks of age (Portha 
et al., 1991). They are characterised by increased blood glucose levels without 
significant alterations in non-fasting plasma insulin levels (Witte et al., 2002). 
Diabetic GK skeletal muscles are characterised by a diminished recruitment of 
the glucose transporter isoform GLUT4 (Mulvey et al., 2005), membrane 
cytoskeletal defects in the dystrophin-dystroglycan complex (Mulvey et al, 2008), 
an inhibition of insulin receptor auto-phosphorylation (Dadke et al., 2000), 
impaired activities of insulin signalling intermediates (Steiler et al., 2003), 
abnormal mitochondrial functioning (Shen et al., 2008) and a reduced percentage 
of oxidative fibres (Yasuda et al., 2002). Since diabetic GK rats are non-obese, 
fundamental mechanisms of type 2 diabetes can be investigated without 
potentially complicating obesity-related factors.  
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The proteomic analysis of normal versus non-obese diabetic skeletal muscles 
presented in this chapter has revealed a moderate differential pattern for 21 
proteins, where 7 proteins where found to be reduced and 14 proteins to be 
increased in there abundance in GK tissue. With respect to neuromuscular 
disorders, the mass spectrometric cataloguing of normal muscle and the profiling 
of genetic and physiological animal models over the last few years have 
established large proteomic maps (Doran et al., 2007). Databanks of biomarkers 
that are implicated in muscular atrophy, fibre transformation, muscular dystrophy 
or age-related muscle wasting are now available for comparative biochemical 
studies (Doran et al., 2007).  In this respect, the proteomic findings of this study 
agree with the idea that diabetes mellitus is associated with a generally perturbed 
protein expression pattern. Insulin resistance appears to be closely related to 
abnormalities in glucose, fatty acid, nucleotide and amino acid metabolism, as 
well as changes in the contractile apparatus, the anti-oxidant defence system, 
detoxification mechanisms and the cellular stress response. 
3.2 Methods 
3.2.1 Animal Model. 
As an internationally established animal model of type 2 diabetes, the 
spontaneous GK rat (Kitahara, 1978) was used in this study. In obesity-related 
diabetes, high levels of circulating free fatty acids and an extensive 
intramyocellular accumulation of triacylglycerol probably play a key role in 
causing decreased tissue sensitivity for insulin. Since the GK rat is non-obese, 
the analysis presented herein eliminates complicating factors due to excess lipids 
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in muscle fibres and focuses instead on the core defects in a spontaneous from 
of type 2 diabetes. Rats were purchased from M&B Taconic Ltd. Animal suppliers 
(Ry, Denmark). For comparative proteomic studies, the accessible protein 
complement was extracted from freshly dissected gastrocnemius muscles from 
9-week-old normal Wistar rats and age-matched GK rats. The validation of the 
diabetic status of the cohort of the GK rats used in this study has been previously 
documented (Mulvey, et al., 2005). Non-fasting blood samples from GK rats 
showed a significant increase in glucose levels in comparison to Wistar rats, but 
plasma insulin levels were relatively comparable between both rat strains. The 
average body weight of the diabetic animals was found to be slightly below that 
of normal rats. 
3.2.2 Preparation of total gastrocnemius muscle extracts. 
  
Muscle samples with a wet weight of 200mg were quick-frozen in liquid nitrogen 
and ground into a fine powder using a mortar and pestle. The muscle powder 
was subsequently placed into 1ml lysis buffer (7M urea, 2M thiourea, 4%(w/v) 
CHAPS, 100 mM DTT and 2% (v/v) pH 3-10 ampholytes), which was 
supplemented with a protease inhibitor cocktail. Following incubation at room 
temperature for 3h, the suspension was centrifuged at 14,000xg for 20min at 
40C. The total protein complement extracted from normal and diabetic tissues 
was quantified by the Bradford method. 
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3.2.3. Two-dimensional gel electrophoresis.  
Total muscle extracts from normal and diabetic muscle tissues were separated in 
the first dimension by isoelectric focusing and in the second dimension by 
sodium dodecyl sulphate polyacrylamide gel electrophoresis, as previously 
described. For the comparative proteomic analysis, 4 biological repeats of normal 
and 4 biological repeats of diabetic samples was used. Isoelectric focusing strips 
were rehydrated in rehydration buffer (7M urea, 2M thiourea, 4% (w/v) CHAPS, 
1.2% deStreak and 2% (v/v) pH 3-10 ampholytes) and 700 mg of muscle protein 
sample for 12 hours. First-dimension protein separation was carried out on an 
Amersham IPGphor IEF system, following the manufacturer’s recommendations 
and the optimized protocol of our laboratory for the separation of skeletal muscle 
proteins. Following chemical reduction and alkylation by a standardized protocol, 
first-dimension strips were carefully placed on top of 12.5% (w/v) slab gels and 
electrophoresed in an Amersham Ettan DALT-Twelve system at 1.5W per gel 
until the bromophenol blue dye front had just ran off the gel. The protein 
separation pattern on two-dimensional gels was visualized by colloidal 
Coomassie Blue, silver or fluorescent RuBPs staining. High-resolution gel 
images where analysed with the Progensis software programme from Non Linear 
Dynamics (Newcastle upon Tyne, UK). 
 
3.2.4. Mass spectrometric identification of muscle proteins.  
In order to unequivocally identify proteins of interest, the peptide mass 
spectrometric analysis of muscle proteins with a changed abundance in diabetic 
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muscle tissue was carried out on a Model 6430 Ion Trap LC/MS apparatus from 
Agilent Technologies (Santa Clara, CA, USA). Excision, washing, destaining and 
treatment with trypsin were preformed by a previously optimised method. 
Trypsin-generated peptides were obtained by removing supernatants from 
digested gel plugs. Further recovery was achieved by adding 30% 
acetonitrile/0.2% trifluoroacetic acid to the gel plugs for 10 min at 37 0C with 
gentle agitation. Resulting supernatants were pooled with the initially recovered 
cohort of peptides following trypsin digestion. Further peptide recovery was 
achieved through the addition of 60% acetonitrile /0.2% t trifluoric acid to each 
plug for 10 min at 370C with gentle agitation. Supernatants were added to the 
peptide pool. The sample was dried through vacuum centrifugation and the 
concentrated peptide fractions were then resuspended in mass spectrometry-
grade distilled water and 0.1% formic acid for identification by ion trap LC-MS 
analysis. Separation of peptides was performed with a nanoflow Agilent 1200 
series system, equipped with a Zorbax 300SB C18 5 µm, 4mm 40nl pre-column 
and an Zorbax 300SB C18 5 µm, 43 mm x 75 µm analytical reversed phase 
column using the HPLC-Chip technology. Mobile phases utilized were A: 0.1% 
formic acid, B: 50% acetonitrile and 0.1% formic acid. Samples were loaded into 
the enrichment at a capillary flow rate set to 2µl/min with a mix of A and B at a 
ratio 19:1. Tryptic peptide fragments were eluted with a linear gradient of 10-90% 
solvent B over 2 l/ min with a constant nano pump flow of 0.6 ml/ min. A 1 min 
post time of solvent A was used to remove sample carry over. The capillary 
voltage was set to 1700V. The flow and the temperature of the drying gas were 
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4l/ min and 300oC, respectively. Database searches were carried out with Mascot 
MS/MS Ion search (Matrix Science, London, UK; MSDB database, release 
20063108). All pI values and molecular masses of identified muscle proteins 
were compared to the relative position of their corresponding two-dimensional 
spots on analytical slab gels. 
 
 
3.3 Results 
3.3.1 Differential protein expression pattern in Wistar rat versus Goto-
Kakizaki rat 
3.3.1.1 Colloidal Coomassie 
In order to determine potential differences in the skeletal muscle proteome from 
normal Wistar rats versus diabetic GK rats, crude total tissue extracts were 
separated by high-resolution two-dimensional gel electrophoresis. The 
gastrocnemius muscle with a mixed fibre type was chosen for the initial 
proteomic survey of diabetic effects on the muscle protein complement, since 
comparative data from numerous proteomic studies exist with respect to this 
muscle (Okumura et al., 2005, Gelfi et al., 2006, Gannon et al., 2008). Figure. 3.1 
shows representative gels of normal versus diabetic muscle preparations stained 
with CBB, silver or fluorescent RuBPs. The high-resolution gels contained 929, 
1236 and 1561 detectable spots in CBB, silver and RuBPs-labelled gels, 
respectively. In general, the two-dimensional spot pattern of the normal muscle 
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protein complement was found to be in agreement with previously published 
studies on the gel electrophoretic separation of total skeletal muscle extracts 
(O’Connell et al., 2007). The protein spot distribution of normal versus diabetic 
preparations did not show extensive differences, but densitometric scanning 
revealed moderate alterations in distinct classes of muscle proteins.  
3.3.1.2 Densitometric analysis of normal versus diabetic skeletal 
muscle. 
Analytical two-dimensional gels were stained with colloidal Coomassie Blue and 
images from normal versus diabetic preparations compared with the help of a 
typhoon Trio variable imager and Progenesis samespot software. Fig. 3.2 shows 
a reference gel of a diabetic rat skeletal muscle used for the mass spectrometric 
identification of proteins with a differential expression profile. Muscle proteins 
with a changed abundance are marked by circles and are numbered 1-23. 
Protein species with a changed abundance in GK gastrocnemuis muscle ranged 
in molecular mass from 15.9 kDa (Cu/Zn superoxide dismutase) to 67.6 kDa 
(dihydrolipoamide s-acetyltransferase of the pyruvate dehydrogenase complex) 
and covered a pI –range from pI 4.9 (ATP synthase) to pI 8.9 (β-globulin). A 
decreased expression was found in the case of seven proteins, and 16 proteins 
were shown to be increased in their abundance. 
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Figure 3.1: Comparative two-dimensional gel electrophoretic analysis of normal 
versus diabetic rat skeletal muscle. Crude total muscle extracts from normal and 
Goto-Kakizaki (GK) muscle tissue were separated in the first dimension by 
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isoelectric focusing and in the second dimension by sodium dodecyle sulfate 
polyacrylamide gel electrophoresis. Shown are Colloidal Coomassie Blue (CCB: 
A and B), silver (C and D) or fluorescent Ruthenium 2 bathophenanthroline 
disulfonate chelate (RuBP’s E and F) stained gels of normal (A, C and E) versus 
diabetic GK muscle (B, D and F). The pH values of the first dimension gel system 
and molecular mass standards (in kDa) of he second dimension are indicated on 
the top and on the left of the panels, respectively. 
 
3.3.1.3 Mass spectrometric identification of proteins with a diabetes-
related change in abundance. 
ESI MS analysis was used to unequivocally identify protein species contained in 
two-dimensional spots with an altered density in normal versus diabetic 
preparations. A list of the 23 muscle-associated proteins that exhibited a 
significantly altered expression level in GK muscle is shown in Table 1. The table 
summarises CCB-stained proteins separated in the pH 3-10 range and outlines 
matched peptide sequences, percentage sequence coverage, Mascot score, the 
relative molecular mass, pI-value, protein accession number and the fold change 
of individual muscle proteins affected by the diabetic phenotype.  
The spot numbers of MS-identified protein species listed in Table 1 correlate with 
the numbering of two-dimensional spots marked in Fig. 2. The majority of 
identified muscle proteins were found to be constituents of various metabolic 
pathways. This included enzymes and transporters involved in glycolysis, the 
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citric acid cycle, oxidative phosphorylation, lypolytic catabolism, nucleotide 
metabolism, carbon dioxide removal, oxygen transportation and amino acid 
catabolism. In addition, components of the contractile apparatus, the cellular 
stress response, anti-oxidant defence mechanisms and formaldehyde 
detoxification appear to be affected in diabetic muscle tissue.  
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Table 1: List of protein species that exhibit a differential expression pattern in normal versus diabetic skeletal 
muscle extracts. The normal versus the diabetic rat skeletal muscle was stained with colloidal Coomassie Blue and 
differentially expressed proteins were identified by ESI-LCMS 
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1 3-hyroyisobutrate dehydrogenase 
 K.DLGLAQDSATSTK.T 
  K.TPILLGSVAHQIYR.M   
K.EAGEQVASSPADVAEK.A  
K.MGAVFMDAPVSGGVGAAR.S 
K.KGSLLIDSSTIDPSVSK.E  
K.EAGEQVASSPADVAEKADR.I  
R.IITMLPSSMNSIEVYSGANGILK.K   
K.DLGLAQDSATSTKTPILLGSVAHQIYR.M 
gi|556389 8.58 36748 11 240 30 -2.2 
2 carbonic anhydrase 3 
 R.GGPLSGPYR.L  
 R.VVFDDTFDR.S  
 K.TILNNGKTCR.V   
K.GDNQSPIELHTK.D   
K.EPMTVSSDQMAK.L 
R.SMLRGGPLSGPYR.L 
  R.VVFDDTFDRSMLR.G 
K.GDNQSPIELHTKDIR.H  
K.DIRHDPSLQPWSVSYDPGSAK.T 
gi|31377484 6.89 29703 10 45 29 -2.2 
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3 
dihydrolipoamide s-
acetyltransferase E2 
component of 2-oxo-
gluterate complex 
 R.GLVVPVIR.N   
R.TINELGEK. 
A  K.LGFMSAFVK.A  
K.VEGGTPLFTLR.K   
K.AKPAEAPATAHK.A   
R.NVETMNYADIER.T 
  K.ASAFALQEQPVVNAVIDDATK.E 
gi|195927000 8.9 49216 8 142 17 -1.8 
4 ATP synthase beta subunit 
 K.ILQDYK.S   
K.IGLFGGAGVGK.T   
K.VVDLLAPYAK.G   
R.GQKVLDSGAPIK.I   
R.TIAMDGTEGLVR.G 
 R.IMNVIGEPIDER.G  
K.AHGGYSVFAGVGER.T   
R.VALTGLTVAEYFR.D   
K.TVLIMELINNVAK.A   
K.VALVYGQMNEPPGAR.A  
 R.LVLEVAQHLGESTVR.T   
R.IMNVIGEPIDERGPIK.T 
 R.IMDPNIVGSEHYDVAR.G    
K.VLDSGAPIKIPVGPETLGR.I  
R.AIAELGIYPAVDPLDSTSR.I  
R.FLSQPFQVAEVFTGHMGK.L   
K.SLQDIIAILGMDELSEEDK.L   
R.IPSAVGYQPTLATDMGTMQER.I  
gi|1374715 4.92 51171 22 341 55 -1.8 
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5 enolase 3, beta 
 K.LGELYK.S  
 K.YNQLMR.I 
 R.IEEALGDK.A  
 R.YLGKGVLK.A  
 K.LSVVDQEK.V   
K.TLGPALLEK.K  
 K.KLSVVDQEK.V   
K.TAIQAAGYPDK.V   
R.LAKYNQLMR.I 
 R.IGAEVYHHLK.G  
 K.FMIELDGTENK.S  
 R.GNPTVEVDLHTAK.G  
 R.GNPTVEVDLHTAK.G   
R.IEEALGDKAVFAGR.K  
 K.FGANAILGVSLAVCK.A  
 K.VVIGMDVAASEFYR.N  
 R.GNPTVEVDLHTAKGR.F   
K.VNQIGSVTESIQACK.L  
 K.VDKFMIELDGTENK.S  
 K.AVEHINKTLGPALLEK.K  
 R.AAVPSGASTGIYEALELR.D  
K.LAMQEFMILPVGASSFK.E  
K.LAMQEFMILPVGASSFK.E  
K.LAMQEFMILPVGASSFK.E  
R.EILDSRGNPTVEVDLHTAK.G  
R.FRAAVPSGASTGIYEALELR.D  
R.SGETEDTFIADLVVGLCTGQIK.T  
K.LAMQEFMILPVGASSFKEAMR.I  
K.TAIQAAGYPDKVVIGMDVAASEFYR.N   
K.DATNVGDEGGFAPNILENNEALELLK.T  
R.HIADLAGNPDLVLPVPAFNVINGGSHAGNK.L  
K.YGKDATNVGDEGGFAPNILENNEALELLK.T 
gi|126723393 7.08 47326 40 817 65 -1.5 
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6 
esterase 
D/formylglutathione 
hydrolase 
 K.KAFNGYLGPDQSK.W 
  K.SGCQQAASEHGLVVIAPDTSPR.G gi|157823267 6.44 31981 2 46 12 -1.5 
7 enolase 1 (alpha) 
 K.YNQILR.I   
R.IEEELGSK.A  
 K.LNVVEQEK.I  
 R.IGAEVYHNLK.N  
 R.GNPTVEVDLYTAK.G  
 R.YITPDQLADLYK.S 
  K.VNQIGSVTESLQACK.L  
 R.AAVPSGASTGIYEALELR.D  
K.LAMQEFMILPVGASSFR.E  
  K.DATNVGDEGGFAPNILENK.E  
K.YGKDATNVGDEGGFAPNILENK.E  
R.HIADLAGNPEVILPVPAFNVINGGSHAGNK.L 
gi|59808815 6.16 47476 14 225 35 -1.5 
8 ATP synthase beta subunit 
 R.TIAMDGTEGLVR.G 
  K.AHGGYSVFAGVGER.T  
 R.TIAMDGTEGLVRGQK.V 
 R.LVLEVAQHLGESTVR.T   
R.IMNVIGEPIDERGPIK.T  
  K.VLDSGAPIKIPVGPETLGR.I  
R.FLSQPFQVAEVFTGHMGK.L 
R.EGNDLYHEMIESGVINLK.D  
gi|1374715 4.92 51171 8 157 21 1.6 
9 adenylate kinase isozyme 1 
 K.IIFVVGGPGSGK.G  
 K.ATEPVISFYDKR.G  
 K.YGYTHLSTGDLLR.A  
 K.VDSSNGFLIDGYPR.E 
  K.GELVPLETVLDMLR.D  
K.IAQPTLLLYVDAGPETMTQR.L   
R.KIAQPTLLLYVDAGPETMTQR.L 
gi|8918488 7.71 21646 12 184 50 1.6 
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10 Cu-Zn soperoxide dismutase 
 R.HVGDLGNVAAGK.D  
 K.DGVANVSIEDR.V  
 R.VISLSGEHSIIGR.T  
 K.GDGPVQGVIHFEQK.A 
gi|203658 5.88 15874 6 155 32 1.6 
11 immunoglobulin light chain  
 K.DSTYSLSSTLTLSK.A  
 R.TVAAPSVFIFPPSDEQLK.S  
 K.VDNALQSGNSQESVTEQDSK.D   
K.VDNALQSGNSQESVTEQDSK.D 
gi|243868 8.47 25892 4 114 22 1.6 
12 phoshoglucomutase 1 
 M.VKIVTVK.T  
 K.VDLSVLGK.Q  
 R.IAAANGIGR.L   
R.LIFADGSR.I   
R.SMPTSGALDR.V  
 R.LSGTGSAGATIR.L  
 K.DLEALMLDR.S  
K.FFGNLMDASK.L  
 K.IALYETPTGWK.F   
K.TIEEYAICPDLK.V   
R.YDYEEVEAEGANK.M  
 K.QFSANDKVYTVEK.A   
K.TQAYPDQKPGTSGLR.K  
 K.ADNFEYSDPVDGSISK.N  
 K.LSLCGEESFGTGSDHIR.E  
R.YDYEEVEAEGANKMMK.D   
K.INQDPQVMLAPLISIALK.V 
gi|77627971 6.14 61642 25 362 42 1.7 
13 Coq 9 protein  
 K.LVQLGQAEK.R   
R.MLIPYIEHWPR.A  
 K.STGEALVQGLMGAAVTLK.N  
 R.YTDQSGEEEEDYESEEQIQHR.I 
gi|51259441 5.5 35095 4 76 19 1.7 
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14 dihydrolipoamide s-acetyltransferase 
 R.VFVSPLAK.K  
 K.ILVPEGTR.D   
K.LIPADNEK.G   
K.DIDSFVPTK.A   
K.GRVFVSPLAK.K   
K.ELNKMLEGK.G  
K.AAPAAAAAAPPGPR.V   
K.YLEKPVTMLL.-  
 K.GIDLTQVKGTGPEGR.I   
R.DVPLGTPLCIIVEK.Q  
 K.VPLPSLSPTMQAGTIAR.W   
R.VAPTPAGVFIDIPISNIR.R   
R.VAPTPAGVFIDIPISNIRR.V  
K.DIDSFVPTKAAPAAAAAAPPGPR.V 
gi|78365255 8.76 67637 14 121 21 1.8 
15 
isocitrate 
dehydrogenase 3 
(NAD+) alpha 
 K.APIQWEER.N   
R.NVTAIQGPGGK.W   
K.IEAACFATIK.D   
R.HMGLFDHAAK.I 
K.CSDFTEEICRR.V   
K.TPIAAGHPSMNLLLR.K 
  K.DMANPTALLLSAVMMLR.H  
R.NVTAIQGPGGKWMIPPEAK.E 
gi|16758446 6.47 40052 8 94 24 1.9 
16 cytochrome c oxidase, subunit Va 
 R.LNDFASAVR.I  
 R.RLNDFASAVR.I   
K.GMNTLVGYDLVPEPK.I   
K.GMNTLVGYDLVPEPK.I 
R.KGMNTLVGYDLVPEPK.I 
gi|24233541 6.08 16354 5 85 17 1.9 
  92
17 
capping protein 
(actin filament) 
muscle z-line, apha 
2 
 R.LLLNNDNLLR.E  
 K.EHYPNGVCTVYGK.K   
K.FTVTPSTTQVVGILK.I   
K.DIQDSLTVSNEVQTAK.E   
K.IQVHYYEDGNVQLVSHK.D  
K.FIIHAPPGEFNEVFNDVR.L  
R.EGAAHAFAQYNLDQFTPVK.I  
K.EATDPRPYEAENAIESWR.T  
K.IVEAAENEYQTAISENYQTMSDTTFK.A 
gi|6671672 5.57 33121 9 162 53 2 
18 Actin a isoform CRA_α 
K.IIAPPER.K  
K.AGFAGDDAPR.A  
R.DLTDYLMK.I  
R.DLTDYLMK.I 
R.GYSFVTTAER.E  
K.EITALAPSTMK.I  
R.AVFPSIVGRPR.H 
gi|149043182 5.23 42372 7 279 16 2.1 
19 heat shock protein 27 HspB1 
R.QLSSGVSEIR.Q  
R.LFDQAFGVPR.F  
R.VSLDVNHFAPEELTVK.T  
K.AVTQSAEITIPVTFEAR.A  
K.YTLPPGVDPTLVSSSLSPEGTLTVEAPLPK.A 
R.KYTLPPGVDPTLVSSSLSPEGTLTVEAPLPK.A
gi|6978487 6.12 22937 2 122 40 2.3 
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20 
fructose-
bisphosphate 
aldolase A 
R.QLLLTADDR.V 
K.GILAADESTGSIAK.R  
K.ADDGRPFPQVIK.S  
M.PHPYPALTPEQK.K  
K.CPLLKPWALTFSYGR.A  
K.IGEHTPSSLAIMENANVLAR.Y  
K.IGEHTPSSLAIMENANVLAR.Y 
K.GVVPLAGTNGETTTQGLDGLSER.C 
K.VDKGVVPLAGTNGETTTQGLDGLSER.C 
gi|6978487 8.31 39791 11 166 37 2.3 
21 beta globulin minor 
 M.VHLTDAEK.A 
  K.ATVSGLWGK.V   
R.LLVVYPWTQR.Y 
  K.VNADNVGAEALGR.L  
 K.EFTPCAQAAFQK.V 
  K.VVAGVASALAHKYH.-  
K.FGDLSSASAIMGNPQVK.A   
K.ATVSGLWGKVNADNVGAEALGR.L  
R.YFSKFGDLSSASAIMGNPQVK.A  
gi|164448680 8.91 16088 10 159 59 2.4 
22 3 mercaptopyruvate sulfertransferase 
 R.FQVVDAR.A 
  R.RFQVVDAR.A  
 R.FQGTQPEPR.D  
 K.LLDASWYLPK.L  
 R.AQPEHVISQGR.G  
 R.ALVSAQWVAEALK.S  
 K.THEDILENLDAR.R   
K.THEDILENLDARR.F  
 K.SPSEPAEFCAQLDPSFIK.T  
R.DGIEPGHIPGSVNIPFTEFLTSEGLEK.S 
gi|20304123 5.88 33209 12 199 36 2.5 
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23 monoglyceride lipase 
R.IDSSVLSR.N  
R.MVVSDFQVFVR.D 
K.GAYLLMESSPSQDK.T 
R.LTLPFLLLQGSADR.L 
gi|19923092 6.92 33826 3 110 10 2.8 
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3.3.1.4 Skeletal muscle proteins with diabetes-associated expression 
changes. 
The two muscle protein species with the highest fold decrease were identified as 
carbonic anhydrase isoform CA3 (spot 1) and 3-hydroxyisobutyrate 
dehydrogenase (spot2). Other proteins with reduced expression level were found 
to be the E2 component of the 2-oxo-glutarate dehydrogenase complex (spot 3) 
enolase (spots 5 and 7) and esterase D formylglutathione hydrolase (spot 6). 
Spots 4 and 8, which were both identified as mitochondrial ATP synthase, 
exhibited decreased and increased levels, respectively. These findings are 
difficult to interpret, but may be due to differential pathological effects on post-
translational modifications in ATP synthase molecules. This might explain the 
opposite alterations in expression levels of two ATP synthase isoforms with 
differing isoelectric points and molecular masses. Muscle-associated proteins 
with an increased abundance in GK muscle preparations were identified as 
adenylate kinase isoform AK1 (spot 9), Cu/Zn superoxide dismutase (spot 10), 
immunoglobulin light chain (spot 11), phosphoglucomutase 9spot 12), Coq 9 
protein (spot 13), the E2 component of the pyruvate dehydrogenase complex 
(spot 14), isocitrate dehydrogenase (spot 15), cytochrome c oxidase (spot 16), 
capping protein of the actin filament (spot 17), alpha-actin (spot 18), stress 
protein Hsp27/B1 (spot 19), fructose-biphosphate aldolase (spot 20), beta-
globulin (spot 21), and 3-mercaptopyruvate sulfurtransferase (spot 22). 
Interestingly, the muscle protein species with the highest fold increase was 
identified as the enzyme monoglyceride lipase (spot 23). 
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 Figure 3.2: Two-dimensional reference gel of diabetic rat skeletal muscle. Shown 
is a colloidal Coomassie Blue stained reference gel of diabetic rat skeletal 
muscle, used for mass spectrometric identification of proteins with a differential 
expression profile. The pH-values of the first dimension gel system and molecular 
mass standards (in kDa) of the second dimension are indicated on the top and 
left of the panel, respectively. Identified muscle proteins are marked by circles 
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and are numbered 1 to 23. See Table 1 for a detailed listing of proteins that 
exhibit a diabetes-associated change in their abundance. 
 
 
3.3.1.5 Silver- and RuBP’s-stained protein candidates with diabetes-
associated expression changes. 
Following the detailed MS-based identification of CBB-stained proteins, diabetes-
related changes in the expression of silver- or fluorescent RuBPs-labelled 
proteins was carried out. Although larger numbers of total protein spots were 
visualized by these two methods, surprisingly no additional components with a 
markedly higher fold changes were identified. Interesting silver-stained proteins 
with a lower abundance in GK muscle were found to be acyl-CoA dehygrogenase 
(gi|56541110|; pI 8.9; 70.8 kDa) and pyruvate kinase (gi|1675994|; pI 6.6; 57.8 
kDa). Fluorescent RuBPs staining revealed a reduced expression of malate 
dehydrogenase isoform MDH-1 (gi|37590235|; pI 6.1; 36.5 kDa) in diabetic tissue 
preparations. 
3.4 Discussion 
Diabetes mellitus and its associated complications affect millions of patients 
worldwide, causing blindness, cardiomyopathy, kidney failure, stroke and skeletal 
muscular weakness (Zimmet et al., 2001). Older adults with type 2 diabetes 
exhibit significantly decreased muscle strength (Park et al., 2006), which is 
thought to be a major contributor to the development of physical disability in the 
senescent population (Gregg et al., 2000). These clinical facts clearly warrant 
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detailed biochemical investigations into the molecular and cellular mechanisms 
that underlie abnormal hormone signalling in diabetic muscle tissue. Insulin 
resistance in peripheral organ systems, representing one of the main features of 
diabetes-related dysregulation, is believed to be already present at a very early 
stage of the pre-diabetic state (Korc et al 2003). In early type 2 diabetes, low 
levels of insulin resistance can probably be partially compensated by increased 
secretion levels via enhanced pancreatic β-cell activity. However, at more 
advanced stages of diabetes, β-cell failure occurs leading to inadequate amounts 
of circulating insulin to overcome defects in tissue sensitivity (Phielix et al., 2003). 
Since type 2 diabetes is an extremely complex and heterogeneous disorder, and 
probably involves both genetic and environmental factors, an unbiased global 
analysis of diabetic tissues by proteomics should be useful to identify novel 
indicators of its molecular pathogenesis. In this respect, the mass spectrometry-
based proteomic survey of diabetic skeletal muscle tissue presented here has 
successfully revealed a variety of expression changes in key muscle proteins. 
However, as compared to more severe muscular defects, the diabetes-related 
expression changes of metabolic enzymes are relatively moderate.  
The proteomic analysis of GK muscles indicates that abundant enzymes, 
transporters and structural components are affected in the non-obese diabetic 
phenotype. This includes muscle-associated proteins involved in glycolysis, the 
citric acid cycle, oxidative phosphorylation, lipolytic catabolism, nucleotide 
metabolism, carbon dioxide removal, oxygen transportation, amino acid 
catabolism, the contractile apparatus, cellular detoxification mechanisms and the 
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stress response. The muscle protein species with the highest fold decrease were 
identified as 3-hydroxy-isobutyrate dehydrogenase and carbonic anhydrase CA3. 
Hydroxy-isobutyrate dehydrogenase is involved in a rate-limiting step of the 
degradation of valine, leucine and isoleucine (Murin et al., 2008). The resulting 
carbon skeleton can be utilized as a metabolic substrate for the generation of 
energy, and this mechanism appears to be weakened in diabetic muscle tissues. 
Interestingly, the CO2-removal mechanism and a specific detoxification 
mechanism seem to be affected in GK muscles. Since the muscle-specific 
isoform CA3 of carbonic anhydrase catalyses the vital conversion of CO2 into 
carbonic acid (Geers et al., 2000), its reduced expression suggests an impaired 
removal of CO2 in diabetic fibres. In addition, a decreased concentration of 
esterase D formylglutathione hydrolase might cause toxic side effects. The 
reduced expression of dihydrolipoamide succinyltransferase, the core enzyme of 
the 2-oxoglutarate dehydrogenase complex in muscle mitochondria that 
participates in succinyl-CoA production (Matuda et al., 1997), agrees with the 
idea of abnormal mitochondrial functioning in diabetes (Mogensen et al., 2007). 
However, other mitochondrial markers such as isocitrate dehydrogenase, 
cytochrome c oxidase and Coq 9 protein (Sohal et al., 2007) were shown to be 
increased in GK muscle, possibly representing a compensatory mechanism to 
improve the oxidative capacity. This would agree with the increased level of beta-
globulin. 
Diabetes seems to have a differential effect on key enzymes of the glycolytic 
pathway. While enolase levels were shown to be decreased, 
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phosphoglucomutase and aldolase exhibited an elevated concentration in GK 
muscles. Since many glycolytic enzymes are multi-functional, it is difficult to 
interpret how insulin resistance triggers these altered expression patterns. 
However, changed abundances in these enzymes will certainly alter the glycolytic 
flux in diabetic muscle. Interestingly, pyruvate dehydrogenase, the key linker 
enzyme that connects glycolysis with the citric acid cycle, is elevated. This might 
be a compensatory mechanism in glucose-starved diabetic muscle tissues and 
might help to maximise the transformation of glycolysis-derived pyruvate into 
acetyl-CoA. In analogy to a recent proteomic survey of obese muscle (Hittle et 
al., 2005), the AK1 isoform of adenylate kinase is increased in diabetes, 
suggesting alterations in nucleotide metabolism. Higher concentrations of the 
contractile elements alpha-actin and the capping protein of the actin filament 
indicate diabetes-dependent repair mechanisms of the thin filament. This would 
agree with increased levels of stress proteins and anti-oxidant markers, such as 
the small heat shock protein Hsp27/B1, 3-mercaptopyruvate sulfurtransferase 
and Cu/Zn superoxide dismutase. Their up-regulation demonstrates a 
considerable need to counter-act cellular damage due to diabetes.  
The protein species with the highest fold increase in GK muscle was identified as 
monoglyceride lipase. This enzyme mediates a critical step in the hydrolysis of 
stored triglycerides (Zechner et al., 2009) and its up-regulation might represent 
increased energy utilization by the lipolytic pathway in glucose-starved muscle 
tissues. More detailed biochemical studies have to be carried out to determine 
the general suitability of monoglyceride lipase as a muscle marker of non-obese 
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diabetes. However, it is clear that insulin resistance results in a lack of glucose 
uptake by muscle cells, which in turn has an effect on other metabolic pathways 
such as gluconeogenesis, triacylglycerol hydrolysis, fatty acid oxidation and 
ketone body formation.  
3.5 Conclusion 
In conclusion, this initial study of changes in the protein expression pattern of GK 
muscle has identified interesting new candidates for the establishment of a 
biomarker signature of diabetic skeletal muscle. It will now be critical to correlate 
these findings to investigations on human skeletal muscle (Hojlund et al., 2003, 
Stentz et al., 2007) and to conduct more detailed studies with other protein dyes 
that exhibit a different dynamic labelling range, such as fluorescent 
methodologies (Viswanathan et al., 2006). In the future, new signature molecules 
will hopefully be useful for the improvement of diagnostic methods and the 
identification of superior therapeutic targets to eliminate diabetes-associated 
muscle weakness 
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 4 Skeletal muscle from the Goto-Kakizaki rat model of 
type 2 diabetes exhibit increased levels of the small heat 
shock protein Hsp27 
 
4.1 Introduction 
The application of gel electrophoresis-based proteomics in diabetes research is a 
fast growing field (Sundsten, 2009), especially in the area of the proteomic 
analysis of diabetic skeletal muscle tissues (Hojlund, et al., 2003, Stentz, et al., 
2007 and Hwang, et al., 2010). Since diabetes appears to be reaching endemic 
proportions, research into the complex pathophysiological mechanisms that 
underlie abnormal signaling in crucial target organs, such as skeletal muscle, is 
of central importance (Petersen et al., 2002, Phielix et al., 2008, Abdul-Ghani et 
al., 2010) . It is now clear that type-2 diabetes mellitus represents a group of 
heterogeneous disorders with abnormal expression patterns in various genes 
and protein products (Scheen et al., 2003, Sander et al., 2003, Tusie-Luna et al., 
2003). Peripheral insulin resistance in the liver, adipose tissue and muscles, as 
well as impaired pancreatic β-cell functioning, are the principal features of type-2 
diabetes (Sander et al., 2003). The worldwide incidence of type-2 diabetes is 
dramatically increasing (King et al., 1998) and the prevalence of diabetes has 
been estimated to rise to a staggering 4.4% by the year 2030 with 366 million 
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affected patients (Wild et al., 2004). Importantly, type-2 diabetes is associated 
with a loss of skeletal muscle mass and contractile strength  (Gregg et al., 2000, 
Andersen et al., 2004, Park et al., 2006) warranting detailed investigations into 
diabetes-related muscle weakness (Mulvey et al., 2008). In this respect, large-
scale biochemical approaches, such as gel electrophoresis-based proteomics, 
are ideal analytical tools for an unbiased identification of novel protein factors that 
are associated with abnormal functioning in diabetic fibres. 
High-resolution two-dimensional gel electrophoresis has long been established 
as one of the most powerful biochemical techniques for the comparative analysis 
of large protein complements (Issaq et al., 2008, Weiss et al., 2009 Westermeier 
et al., 2009). The more recent combination of advanced gel electrophoretic 
methods with mass spectrometry has further reinforced the central importance of 
gel electrophoretic techniques for analytical protein chemistry (Gorg et al., 2004, 
Wittmann-Liebold et al., 2006, Rabilloud et al., 2009). The unprecedented 
advancements of mass spectrometric methods for the swift identification of 
minute amounts of protein (Domon et al., 2006) and the emergence of high-
throughput proteomics as a major new field in modern biochemistry (Canas et al., 
2006) have opened unparalleled opportunities for the in-depth analysis of 
complex pathological processes. However, a major obstacle for the inclusive 
cataloging of large and diverse protein complements is the dynamic 
concentration range of protein species within a given class of cells or tissues. 
Since different staining techniques used in two-dimensional gel electrophoresis 
visualize varied dynamic expression ranges, protein labeling may considerably 
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influence proteomic identification protocols. Here, we have used fluorescence 
difference in-gel electrophoresis (DIGE) for the determination of potential 
expression changes in the soluble proteome from normal Wistar rat muscle 
versus type-2 diabetic Goto-Kakizaki (GK) rat muscle. The GK rat is an 
established animal model of non-obese type-2 diabetes (Kitahara et al., 1978) 
that exhibits peripheral insulin resistance (Abdel-Halim et al., 1994) and 
numerous molecular and cellular abnormalities due to its diabetic status (Portha 
et al., 1991, Witte et al., 2002), including abnormal skeletal muscle functions 
(Krook et al., 1997, Dadke et al., 2000, Mulvey et al., 2005, Shen et al., 2008).  
Our comparative mass spectrometry-based proteomic analysis revealed a 
moderately disturbed protein expression pattern in diabetic muscle fibres. Mass 
spectrometry identified 15 distinct 2-D protein spots with an altered abundance in 
diabetic muscle tissue preparations, using analytical DIGE gels with a pH 3-10 
range. Besides altered expression patterns in various contractile and metabolic 
muscle proteins, a striking increase in two heat shock proteins (Hsp), αB-
crystallin and Hsp27, was established by densitometric scanning and mass 
spectrometry. Muscle-associated Hsps protect contractile fibres during 
hyperthermia, hypoxic insult, ischemic damage, extensive periods of exercise, 
traumatic injury and in numerous neuromuscular diseases (Nishimura et al., 
2005). Hsps of low molecular mass are specifically induced during muscle injury 
(Golenhofen et al., 2004), whereby their main cytoprotective functions include the 
prevention of deleterious protein aggregation and the modulation of intermediate 
filament assembly (Nicholl et al., 1994). Small Hsps are characterized by a 
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conserved 90-residue carboxy-terminal sequence, the α-crystallin domain (van 
Montfort et al., 2001). These small cytoprotective chaperones appear to be up-
regulated in GK muscle tissue. Hence, diabetes-related changes in the cellular 
stress response, the contractile machinery, metabolic pathways and various 
regulatory mechanisms are possibly linked to peripheral insulin resistance in 
skeletal muscles. In the future, these novel signature molecules might be helpful 
for the establishment of a comprehensive biomarker signature of type-2 diabetes 
mellitus. 
4.2  Methods 
4.2.1  Diabetic animal model.  
For the comparative proteomic analysis of normal versus diabetic muscle tissue, 
normal Wistar rats and the spontaneous diabetic Goto-Kakazaki (GK) rat were 
used in this study. The GK rat is an established model of non-obese type-2 
diabetes. Rats were purchased from M & B Taconic Ltd. Animal Suppliers (Ry, 
Denmark). The total soluble proteome was extracted from gastrocnemius 
muscles from 9-week old normal rats and age-matched GK rats. The diabetic 
status of the cohort of GK rats employed in this study has previously been 
described in detail. 
 
4.2.2.  Preparation of muscle extract.  
Gastrocnemius muscle samples from normal and GK rats with a wet weight of 
200 mg were quick-frozen in liquid nitrogen and then ground into a fine powder 
using a mortar and pestle. The muscle powder was transferred into 1ml lysis 
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buffer containing 2% (v/v) pH 3-10 ampholytes, 7M urea, 2M thiourea, 4%(w/v) 
CHAPS and 100 mM dithiothreitol.  A freshly prepared protease inhibitor cocktail 
was added to the buffer to prevent proteolytic degradation of sensitive muscle 
proteins. The suspension was incubated for 3 hours at room temperature and 
then centrifuged at 14,000xg for 20min at 40C. The Bradford dye-binding method 
was used to determine the protein concentration of the final extracts from normal 
versus GK muscle tissue. 
 
4.2.3.  Gel electrophoretic analysis.  
Total crude skeletal muscle extracts of normal (n=4) and diabetic (n=4) muscle 
tissues were separated in the first dimension by isoelectric focusing and in the 
second dimensional by standard sodium dodecyl sulphate polyacrylamide gel 
electrophoresis, as previously described by our laboratory. IPG strips were 
rehydrated for 12 hours in a buffer consisting of 7M urea, 2M thiourea, 4% (w/v) 
CHAPS, 1.2% deStreak and 2% (v/v) pH 3-10 ampholytes. The buffer system 
contained 400 µg of muscle protein. The first-dimension protein separation was 
conducted using IPG strips on an Amersham IPGphor IEF system (Amersham 
Bioscience/GE Healthcare, Little Chalfont, Bucks, UK) following the protocol 
previously described in detail. The first dimension strips were further subjected to 
reduction and alkylation before separation in the second-dimension on 12.5% 
(w/v) slab gels using an Amersham Ettan DALT-Twelve system.  
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4.2.4.  Protein Visualisation.  
For DIGE analysis, Cy3 and Cy5 dyes were reconstituted as a stock solution of 
1mM in fresh dimethylformamide. The stock solution was diluted to a working 
solution of 0.2 mM prior to protein labelling. Individual samples (50 µg protein) 
were minimally labelled with 200 pmols of Cy3 working solution. A pooled sample 
consisting of equal quantities of protein from all replicates used in the experiment 
were labelled at a ratio of 200 pmol of Cy5 working solution to 50 µg of muscle 
protein. All samples were labelled with the appropriate amount of dye at pH 8.5 
and then incubated on ice in the dark for 30 minutes. The reaction was quenched 
by 10 mM lysine for 10 minutes on ice in the dark. During the subsequent 
rehydration step, samples were loaded onto IPG strips with an equal volume of 
2x sample buffer (7M urea, 2M thiourea, 65mM CHAPS, 2% ampholytes and 2% 
dithiothreitol). Slab gels were stained for total protein with Coomassie Brillinat 
Blue or ruthenium bathophenanthroline disulfonate (RuBPs). A stock solution of 
RuBPs dye was prepared as described by Rabilloud et al. Two-dimensional gels 
were fixed overnight in 30% (v/v) ethanol and 10% (v/v) acetic acid and 
subsequently washed 4 times for 30 min in 20% (v/v) ethanol to remove traces of 
acetic acid. The ruthenium fluorophore was then applied to the gels by adding 10 
ml of the freshly synthesized dye to 1 litre of 20% (v/v) ethanol in the dark. Gels 
were incubated for 6 hours in the staining solution. Labelled gels were then 
destained in 40% (v/v) ethanol and 10% (v/v) acetic acid. Reference gels for spot 
picking were stained with Commasie Brillinat Blue. Gel images were analysed 
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using Progenesis SameSpots software version 3.2.3 from NonLinear Dynamics 
(Newcastle upon Tyne, UK) 
 
4.2.5.  Mass spectrometric identification of skeletal muscle proteins.  
The mass spectrometric analysis of peptide mixtures derived from distinct two-
dimensional spots was carried out on a Model 6430 Ion Trap LC/MS apparatus 
from Agilent Technologies (Santa Clara, CA, USA). The excision of protein spots 
and subsequent washing, destaining and digestion steps were preformed by a 
previously optimised method. Trypsination-generated peptides were recovered 
from supernatants of digested gel plugs and samples dried through vacuum 
centrifugation. The resulting peptides were resuspended in 10 l of MS-grade 
ddH2O and 0.1% (w/v) formic acid for identification by ion trap LC-MS analysis. 
Separation of peptides was performed with a nano flow Agilent 1200 series 
system, equipped with a Zorbax 300SB C 185 mm, 4 mm 40nl pre-column and a 
Zorbax 300S B C 185 mm, 43mm x 75μm analytical reversed- phase column 
using HPLC-Chip technology. Mobile phases utilized were A: 0.1% formic acid, 
B: 50% acetonitrile and 0.1% formic acid. Samples (5 l) were loaded into the 
enrichment at capillary flow rate set to 2 l/min with a mix of A and B at a ratio 
19:1. Tryptic peptides were eluted with a linear gradient of 10-90% solvent B over 
2 l/ min with a constant nano pump flow of 0.6 ml/ min. A 1 min post time of 
solvent A was used to remove sample carry over. The capillary voltage was set 
to 1700 V. The flow and the temperature of the drying gas were 4 l/ min and 
  110
300oC, respectively. Database searches were carried out with Spectrum Mill 
Work Bench or Mascot MS/MS Ion search (Matrix Science, London, UK). 
 
4.2.6.  Immunoblot analysis.  
To verify changes in the abundance of select proteins in GK muscle preparations, 
immunoblotting was carried as previously described in detail. Gels were 
transferred to nitrocellulose and blocked with a milk protein solution consisting of 
5% (w/v) fat-free milk powder in 0.9 % (w/v) NaCl, 50 mM sodium phosphate, pH 
7.4 for 1h. Subsequently, membranes were incubated overnight with sufficiently 
diluted primary antibody, washed and then incubated for 1h with secondary 
peroxidase-conjugated antibodies, diluted in blocking solution. The visualization 
of immuno-decorated bands was carried out by the enhanced 
chemiluminescence method using blotting substrate from Roche Diagnostics 
(Mannheim, Germany). Densitometric scanning of immunoblots was performed 
on a Molecular Dynamics 300S computing densitometer (Sunnyvale, CA, USA) 
with ImageJ (NIH, USA) and GraphPad Prism (San Diego, CA, USA) software. 
 
4.3 Results 
 
4.3.1  Proteomic analysis of diabetic GK muscle extracts. 
Difference in-gel electrophoresis (DIGE) represents an excellent analytical tool 
for large-scale proteomic surveys  (Tonge et al., 2001, Marouga et al., 2005, 
Viswanathan et al., 2006) and this method was applied here for the comparative 
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analysis of normal versus diabetic muscle extracts. With the help of a Typhoon 
Trio variable imager and Progenesis 2-D analysis software, 15 protein species 
out of 1734 detectable 2-D spots were found to be differentially expressed. 
Representative Cy3  and Cy5 gels with electrophoretically separated proteins 
from normal versus diabetic muscle tissue are shown for the pH 3-10 range in 
Fig. 4.1a-d. The protein spot patterns of normal versus pathological preparations 
were relatively comparable. However, the detailed densitometric analysis of 
Wistar rat versus GK rat muscle tissue identified distinct changes in a variety of 
protein species. A representative DIGE master gel of GK rat skeletal muscle 
preparations employed for the mass spectrometric identification of proteins with a 
diabetes-related differential expression pattern is shown in Figure. 4.1e. Skeletal 
muscle proteins that exhibited a more than 2-fold change in expression levels are 
marked by circles and are numbered 1 to 15. Proteins species with a changed 
concentration in GK gastrocnemius muscle ranged in molecular mass from 16 
kDa (hemoglobin) to 223 kDa (myosin heavy chain) and covered a pI-range from 
pI 4.1 (troponin) to pI 8.9 (bisphosphoglycerate mutase). An increased 
abundance was found in the case of 10 skeletal muscle-associated proteins, and 
5 proteins were shown to be decreased in their concentration. 
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 Figure 4.1. Proteomic profiling of diabetic rat GK skeletal muscle using fluorescent DIGE 
analysis and RuBPs staining. Crude total muscle extracts from normal and Goto-Kakizaki (GK) 
gastrocnemius muscle tissue were separated in the first dimension by isolelectric focusing and in 
the second dimension by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Shown are 
Cy3-labeled control samples (a), Cy3-labeled diabetic GK samples (b) and Cy5-labeled pooled 
standards (c, d). A DIGE master gel with a pH 3-10 range is shown in panel (e). Identified muscle 
proteins are marked by circles and are numbered 1 to 15. See Table 1 for a detailed listing of 
protein species that exhibited a diabetes-related alteration in their expression levels. To verify the 
changed abundance in the molecular chaperone Hsp27 (spot no. 10), fluorescent ruthenium 
bathophenanthroline disulfonate (RuBPs) staining was used (f). The 2D-spot representing Hsp27 
is marked by a circle. The pH-values of the first dimension gel system and molecular mass 
standards (in kDa) of the second dimension are indicated on the top and on the left of panels (e, 
f), respectively. The mass spectrometric fingerprint of Hsp27 is shown in panel (g). 
 
4.3.2  Proteomic profile of diabetic skeletal muscle tissue.  
A list of the 15 DIGE-identified muscle proteins, which exhibited a drastically 
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altered expression level in the non-obese diabetic GK rat, is shown in Table 4.1. 
Listed are the names of the identified proteins, their international protein 
accession number, pI-values, their relative molecular masses, number of 
matched peptide sequences, percentage sequence coverage, Mascot scores, 
and fold-change of individual proteins affected in diabetic muscle tissue. The 
identified muscle proteins were found to be mostly associated with the contractile 
apparatus, muscle metabolism, metabolite transportation and the cellular stress 
response. The numbering of spots in the DIGE-labeled master gel of Fig. 4.1e 
correlates with the listing of mass spectrometry-identified protein species in Table 
4.1. The protein with the highest decrease in concentration was identified as 
bisphosphoglycerate mutase and that with the highest increase in abundance 
shown to be the fast 1f-isoform of myosin light chain. Muscle proteins with a 
drastic decrease were found to be bisphosphoglycerate mutase (spot 1), myosin 
heavy chain 4 (spot 2), troponin C (spot 3), Tip1 protein (spot 4) and hemoglobin 
(spot 5). In contrast, muscle proteins with an increased expression in diabetic 
muscle tissue were identified as fast troponin T (spots 6 and 11), tropomyosin 
(spot 7), slow myosin light chain 3 (spot 8), fast myosin light chain 1f (spots 9 and 
15), Hsp27 (spot 10), αB-crystallin (spot 12), myozenin (spot 13) and myoglobin 
(spot 14). 
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Table 4.1  DIGE‐identified proteins with a changed abundance in diabetic 
GK muscle extracts  
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1 bisphosphoglycerate mutase 2 gi8393948 8.85 28911 16 185 43 -3.3 
2 
myosin heavey 
chain 4, skeletal 
muscle 
gi|106879208 5.58 223669 17 181 7 -2.4 
3 troponin C, type 2 gi|82654194 4.06 18142 19 482 65 -2.2 
4 Tip1 protein  gi|38512111 7.07 27228 26 459 81 -2.1 
5 major beta-hemoglobin gi|204570 7.88 16099 3 141 28 -2 
6 troponin T, fast skeletal muscle gi|136385 6.19 30732 2 78 11 2 
7 Tropomyosin 2, beta gi|11875203 4.66 32933 16 361 33 2.1 
8 
myosin, light chain 
3, alkali; ventricular, 
skeletal, slow 
gi|6981240 5.03 22258 16 288 75 2.1 
9 fast myosin alkali light chain 1f gi|117676401 4.99 20782 9 113 51 2.1 
10 heat shock protein 27 gi|1170367 6.12 22937 11 119 60 2.4 
11 troponin T, fast skeletal muscle gi|136385 6.19 30732 4 86 15 2.4 
12 alpha B-crystallin gi|57580 8.84 19945 13 204 55 2.5 
13 myozenin 1  gi|157819165 8.57 31379 2 109 11 2.6 
14 myoglobin gi|11024650 7.83 17204 2 98 21 3.2 
15 fast myosin alkali light chain 1f gi|117676401 4.99 20782 6 125 31 3.4 
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4.3.3  RuBPs analysis of Hsp27 in GK muscle extracts. 
To verify the increased levels of the low-molecular-mass molecular chaperone 
Hsp27 in GK muscle, as revealed by DIGE analysis, the fluorescent dye 
ruthenium bathophenanthroline disulfonate (RuBPs) was employed for labeling 
electrophoretically separated muscle proteins. As illustrated in Fig. 4.1f, a protein 
spot with an approximate pI value of 6 and a relative molecular mass of 27 kDa 
was identified as Hsp27/HspB1. The mass spectrometric fingerprint of the 
RuBPs-stained Hsp27 protein spot is shown in Fig. 1g and illustrates 60% 
coverage of matched peptides. Thus, the densitometric analyses of two 
independent fluorescent labeling approaches agreed and clearly demonstrated a 
drastic increase in the small stress protein Hsp27.  
 
4.3.4. Immunoblot analysis of GK muscle extracts.  
In order to correlate the findings of the DIGE-based study described here and a 
previously published proteomic survey of GK muscle using Coomassie Brillinat Blue, an 
immunoblot analysis was carried out with normal versus GK preparations. Both, the 
drastic diabetes-related increase in Hsp27 and the actin binding-protein myozenin were 
clearly confirmed by immunoblotting (Fig. 4.2a, b, g). The previously established drastic 
decrease in carbonic anhydrase isoform CA3 and moderate increase in isocitrate 
dehydrogenase, Cu/Zn superoxide dismutase and actin capping-protein were also 
confirmed (Fig. 4.2c-f, h). Hence, immunoblotting verified the increased abundance of 
Hsp27 in diabetic GK muscle tissue and the differential expression pattern of other 
novel muscle-associated marker proteins of type 2 diabetes. 
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 Figure 4.2. Immunoblot analysis of diabetic rat GK skeletal muscle. Shown 
are representative immunoblots with expanded views of immuno-decorated 
bands. Immunoblotting was performed with antibodies to the molecular 
chaperone Hsp27 (a), the actin binding protein myozenin (b), the enzyme 
isocitrate dehydrogenase (c; ICDH), the enzyme Cu/Zn superoxide dismutase (d; 
SOD), actin capping-protein (e; CP) and the enzyme carbonic anhydrase isoform 
CA3 (f). Shown is the graphical presentation of the statistical evaluation of 
immuno-decoration using antibodies to Hsp27 (g) and carbonic anhydrase CA3 
(h). The comparative blotting was statistically evaluated using an unpaired 
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Student’s t-test (n=5; *p<0.05; **p<0.01). Lanes 1 and 2 represent normal and 
diabetic muscle extracts from control and GK rats, respectively. 
4.4 Discussion 
The GK rat is an established animal model of non-obese type-2 diabetes. 
Importantly, these animals are spontaneously diabetic (Kitahara et al., 1978) and 
clearly exhibit increased blood glucose levels without significant alterations in 
non-fasting plasma insulin levels and body weight (Abdel-Halim et al., 1994, 
Portha et al., 1991, Witte et al., 2002, Krook, et al., 1997) . We chose GK muscle 
tissues because they represent a suitable model system for studying 
fundamental mechanisms of type 2 diabetes without potentially complicating 
factors due to obesity. It is important to stress that no animal model represents a 
perfect replica of all pathobiochemical aspects seen in a highly complex human 
pathology. However, if one keeps in mind species-specific differences, findings 
from animal model proteomics can be extrapolated to the human situation (Doran 
et al., 2007). Ideally, a diabetic animal model should closely resemble the 
etiology of the human disease in onset, progression, complexity and severity, as 
well as develop all or most of the multi-factorial aspects usually observed in end-
stage human pathology. A good model system should also mimic the basic 
mechanisms of human physiology and metabolism that are important for the 
development of diabetic side effects. It is therefore critical to choose the right age 
range of pathological GK tissues to study diabetic dysfunctions at a prominent 
stage of disease progression. It was previously reported that cellular defects in 
insulin secretion and peripheral insulin resistance occur by 4 weeks of age in the 
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GK rat (Abdel-Halim et al., 1994, Portha et al., 1991). The proteomic profiling of 
diabetic muscle described here was therefore performed with 9-week old animals 
that clearly exhibited elevated levels of glucose (Mulvey et al., 2005). 
Diabetic GK skeletal muscles are characterized by an inhibition of insulin 
receptor auto-phosphorylation (Krook et al., 1997), impaired activities of 
numerous key insulin signaling intermediates (Witte et al., 2002, Dadke et al., 
2000), a diminished recruitment of glucose transporter GLUT4 molecules 
possibly linked to membrane cytoskeletal defects in the dystrophin-dystroglycan 
complex (Mulvey et al., 2005, Mulvey et al 2008), drastically lowered 
mitochondrial enzyme activities (Shen et al., 2008) and a reduced percentage of 
oxidative fibres (Yasuda et al., 2002). These findings demonstrate chronically 
impaired insulin signaling in GK skeletal muscles making them a suitable model 
system to determine global changes in the protein expression pattern due to 
diabetic complications. The proteomic analysis presented here has clearly shown 
increased levels of the small chaperone Hsp27, also termed HspB1 (van Montfort 
et al., 2001), in GK muscle preparations. Importantly, results of our DIGE 
analysis were confirmed by fluorescence RuBPs labeling and immunoblotting. 
This report therefore confirms the findings of a previous proteomic 
characterization of GK muscle using Coomassie Brilliant Blue staining (Mullen et 
al., 2010) and suggests a considerable up-regulation of specific low-molecular-
mass chaperones in diabetic muscle tissue. The main cytoprotective functions of 
small Hsps include the modulation of intermediate filament assembly and the 
prevention of deleterious protein aggregation (Nicholl et al., 1994). In addition, 
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increased levels of Cu-Zn superoxide dismutase (Miao et al., 2009) suggest a 
critical need of diabetic muscles for an up-regulation of the anti-oxidant defense 
system. Thus, in analogy to dystrophic and aged skeletal muscles (Doran et al., 
2006, Doran et al., 2007), contractile tissue seems to be associated with 
considerable levels of cellular stress due to type-2 diabetes. 
In addition, the proteomic screening of GK muscle tissue also revealed protein 
alterations in the contractile apparatus and metabolic elements, suggesting a 
generally perturbed protein expression patterns due to diabetic side effects. 
These diabetes-related changes might be directly or indirectly associated with 
peripheral insulin resistance. The status of these the newly identified markers of 
type 2 diabetes has now to be verified by detailed biochemical, physiological and 
cell biological characterizations in order to establish a reliable biomarker 
signature of diabetes mellitus. Differential expression patterns of crucial 
contractile proteins agree with the concept of impaired muscle strength in 
diabetes (Gregg et al., 2000, Park et al., 2006, Park et al., 2009). The pattern of 
altered abundance in contractile and regulatory elements does not indicate a 
fibre type-specific shift. On the one hand, protein spots representing myosin 
heavy chain 4 and troponin C were decreased in GK muscle. On the other hand, 
crucial contractile elements such as slow and fast isoforms of myosin light chain, 
myozenin and fast troponin T were found to be increased in diabetic 
preparations. Thus, in agreement with previous studies that have shown marked 
pathophysiological alterations in GK rat tissues (Steiler et al., 2003, Shen et al., 
2008) and diabetic specimens from patients (Hojlund et al., 2003 Stentz et al., 
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2003), the results presented here confirm the drastic effects of type 2 diabetes on 
voluntary contractile fibres.  
In the field of neuromuscular pathology, there is an urgent need for the 
establishment of disease-specific biomarker signatures that can be used to 
differentiate between common changes due to general fibre degeneration versus 
pathobiochemical mechanisms that are unique to a particular muscular disorder. 
Various proteomic profiling programmes have been initiated to identify novel 
signature molecules of muscular atrophy, muscular dystrophy, muscle 
transformation and age-related muscle wasting (Ohlendieck et al., 2010). In our 
experience, it is advisable to initially carry out small-scale pilot experiments to 
determine the general suitability of different protein dyes for specific proteomic 
applications. Thus, besides taking into account differing electrophoretic mobilities 
of soluble versus integral proteins, it is also important to keep in mind the affinity 
of diverse classes of proteins for different dye staining protocols. Here, we have 
shown that the DIGE method and the fluorescent dye RuBPs are highly suitable 
to determine protein alterations in the non-obese diabetic GK gastrocnemius 
muscle. In conclusion, the proteomic identification of the biomarker signature of 
diabetic effects on skeletal muscle may be useful for complementing future 
physiological and biochemical investigations into the molecular mechanisms of 
peripheral insulin resistance (Korc et al., 2003). The newly established tissue-
specific combination of disease markers might also be exploitable in the 
evaluation of the effects of novel drug regimes, gene therapy approaches or cell-
based therapies for counter-acting serious side effects of type 2 diabetes in 
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peripheral tissues. 
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 Chapter 5  
Enrichment and Analysis 
of the Mitochondrial 
Proteome 
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5 Enrichment and Analysis of the Mitochondrial 
Proteome 
5.1 Introduction 
5.1.1 Mitochondria 
Depending on the function of the cell in question, hundreds to thousands of 
mitochondria may be present. For example muscle cells have more mitochondria 
than other cells due to the high energy demands of these cells. Mitochondria are 
organelles consisting of a double membrane, and the space between them is the 
inter membrane space. Cristae are projections formed from the many 
invaginations of the inner membrane. The cristea greatly increases the surface 
area of the inner membrane, which is the site of ATP generation, a process of 
great importance in muscle due to its high energy demands. 
The citric acid cycle is responsible for the breakdown of acetyl CoA, as well as 
the synthesis of ATP. Acetyl CoA is produced via the breakdown of pyruvate, the 
final product of glycolosis. The conversion of acetyl CoA and oxaloacetate to 
citrate signifies the initial step of the citric acid cycle.  The pyruvate 
dehydrogenase converts pyruvate to acetyl CoA by importing pyruvate into the 
mitochondrial matrix. Over a cascade of several reactions, one triggering the start 
of another, oxaloacetate is reformed (Krebs et al. 1980). These reactions result in 
the production of NADH which is used during oxidative phosphorylation. 
Oxidative phosphorylation occurs by the transfer of energy stored within the 
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carbon bonds of glucose to the third phosphate bond of ATP. In this complex 
reaction energy is transferred as electrons, manipulating the dinucleotide electron 
carriers NADH and flavin adenine dinucleotide (FADH2), across a series of 
protein complexes bound to the inner mitochondrial membrane. This transfer of 
electrons is coupled with the transportation of protons from the matrix to the 
intermembrane space, creating a proton gradient between the two 
compartments. After the transfer of electrons between four complexes, (Complex 
1 NADH dehydrogenase, Complex 2 Succinate dehydrogenase, Complex 3 
cytochrome C reductase, Complex 4 cytochrome C oxidase), a fifth complex 
(ATP synthase) is responsible for the re-entry of protons to the matrix from the 
intermembrane space.  Complexes 1, 3 and 4 are reduction- and oxidation-driven 
proton pumps that use energy carried by electrons to pump protons out of the 
matrix, creating the proton electrochemical gradient. ATP synthase utilises the 
available energy within the electrochemical gradient to drive the synthesis of ATP 
from ADP and Pi (Saraste 1999). Other processes such as haeme biosynthesis, 
apoptosis and fatty acid metabolism (Mannaerts et al. 1979; Antonsson et al. 
2000; Sano et al. 1959) require mitochondrial involvement. For these cellular 
functions and for general normal cell function, it is critical that mitochondria 
remain intact and fully functional. 
 It is well established that mitochondrial function is required for normal 
glucose-stimulated insulin secretion from pancreatic b cells. Insulin resistant 
conditions resembling Type 1 Diabetes caused by maternal inheritance of 
defected mitochondrial DNA that perturbs mitochondrial function have also been 
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well documented. On this note, recent studies utilising magnetic resonance 
spectroscopy (MRS) have shown that more understated defects in mitochondrial 
function might also play a role in the pathogenesis of insulin resistance in T2D (K, 
F, Petersen et al. 2002). In the same study it was also shown that in young 
insulin-resistant offspring of parents with T2D, the insulin resistant subjects were 
found to have a lower ratio of type 1 to type 2 muscle fibres. Type 1 fibres are 
mostly oxidative and contain more mitochondria than type 2 muscle fibres, which 
are more glycolytic.  
Glucose detection requires oxidative mitochondrial metabolism, which leads to 
the generation of ATP. The increased concentration of ATP to ADP initiates the 
deactivation of the ATP/ADP-regulated potassium channel (KATP) which causes 
the depolarisation of the plasma membrane. An influx of calcium ions is 
experienced due to the opening of voltage sensitive calcium channels which 
open when the plasma membrane becomes depolarised. The influx of calcium 
ions triggers the secretion of insulin.  β cell dysfunction in T2D is believed to be 
secondary to increased exposure of β cells to glucose (glucotoxicity) and/or lipids 
(lipotoxicity) (R. H. Unger et al., 1995; M. Prentki et al., 2002). However it is 
possible, due to the central role of mitochondria in glucose sensing, that reduced 
mitochondrial activity in β cells may prompt individuals to eventually develop β 
cell dysfunction and T2D.  
5.1.2 Mitochondria and Type 2 Diabetes 
Mitochondrial dysfunction in muscle has been implicated to play a causative role 
or being an indirect consequence of insulin resistance in type 2 diabetes. Besides 
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involvement in intermediary metabolism, protein transport, cell cycle progression, 
calcium signalling and regulation of apoptosis, mitochondria represent the 
primary site for energy generation via oxidative phosphorylation. Cellular 
dysfunction of muscle mitochondria is believed to play a crucial part in triggering 
insulin resistance (Lowell et al., 2005). It is not clear whether mitochondrial 
abnormalities are secondary consequence of impaired hormonal signalling or the 
actual primary cause for a diminished glucose uptake into peripheral tissues 
(Pagel-Langenickel et al., 2010).  
For many obese individuals frank diabetes never develops and the pancreatic    
cells adapt to meet the bodies requirements for insulin. This adaption develops 
via the expansion of the  cell mass. For individuals who develop type 2 diabetes 
the b cells of the pancreas do not produce enough insulin to compensate for the 
demand for the hormone. Often the lack of insulin is due to the b cells not 
expanding or to meet the new requirements or failure of the b cells to respond or 
sense glucose. Several studies have reported that for individuals with type 2 
diabetes glucose sensing is impaired and therefore the required amounts of 
insulin are not secreted (Liu et al., 2002).  
 
5.1.3 Subcellular Proteomics 
The separation of protein cell extracts via 2-D gel electrophoresis is a powerful 
technique which presents the possibility to separate as many as 2,000 proteins 
on one large slab gel.  However, there are limitations to how much protein can be 
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visualised in the second dimension of a slab gel as well as the issue of masking, 
where larger, more abundant proteins can hide less abundant proteins because 
they migrate to similar points on the gel due to similar pI’s and molecular masses, 
and therefore limit the scope of the analysis. Another limiting factor is the volume 
of protein, which can be applied to the first dimension separation by isoelectric 
focusing (IEF), here again more abundant proteins can often enter the gel with 
the exclusion of others.   
Overcoming these limitations has given rise to many different techniques such as 
preferential staining, as well as to separate cellular components into less 
complex mixtures, allowing an enrichment of a particular cell component or 
organelle.  In other words, to reduce the complexity of the analyte. Sub cellular 
fractionation is a useful technique for isolating proteins associated with 
organelles such as mitochondria. There are many examples of researchers 
manipulating differential centrifugation and other fractionation techniques (charge 
fractionation, affinity fractionation, immunoprecipitation and size fractionation) to 
enrich for specific cellular compartments such as lysosomes, endosomes, rough 
endoplasmic reticulum (ER), golgi apparatus and centrosomes. Combined with 
narrow pH gradients in the first dimension, a less complex analyte will allow for 
greater separation and visualisation of a larger number of proteins (Westbrook et 
al. 2001). In every subcellular proteomic investigation, a pertinent question is a 
discussion of the purity of the fraction. Mitochondrial preparations are often found 
to be contaminated with cytosolic, microsomal and ER proteins. In this study the 
enrichment of mitochondria from the non-obese Goto-Kakizaki rat was conducted 
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to consider changes in the mitochondrial proteome and to highlight any possible 
mitochondrial biomarkers of Type 2 Diabetes.  
5.1.4  DIGE analysis 
Two dimensional polyacrylamide gel electrophoresis (2D-PAGE) has been the 
workhorse of proteomics allowing for the resolution of several thousand proteins 
in a single sample. Often a lack of reproducibility between conventional 2D-
PAGE gels leads to significant system variation and induced biological change, 
which means that real differences between protein abundances attributed to, for 
example, a diseased state can rarely be predicted with confidence. 2D 
fluorescent Difference in Gel Electrophoresis (DIGE) can dramatically simplify the 
process by enabling up to three different samples to be run on the same 2D 
gel.DIGE is a 2-D gel electrophoresis technique that utilises ester cyanine dyes. 
The technique involves labelling proteins with cyanine dyes before 2-D gel 
electrophoresis.  The method was first described by Unlu et al., 1997. As 
previously described in chapter 4, only two dyes were synthesised first which 
were Cy3 and Cy5. These dyes label proteins by forming covalent bonds with the 
primary amine of the amino acid lysine resulting in an amide linkage between the 
dye and the protein. Cy3 and Cy5 have the same reactive group and the same 
molecular mass. These two factors ensure equal labelling but with a separate 
emission spectra and excitation. Cy2 is another cyanine dye but it differs to Cy3 
and Cy5 in that it is not as diverse as they are. Cy2 is not ideally mass matched 
and also it experiences an overlap in excitation spectra with Cy3.  Recent DIGE 
studies have shown that the use of only Cy3 and Cy5 reaps a much lower 
  129
variance and therefore diminishing the need for higher number of replicates (Karp 
et al. 2005).  
 A unique feature of DIGE experiments is the inclusion of a pooled internal 
standard. This concept was first introduced by Alban et al 2003. In this 
publication the internal standard was prepared by pooling equal amounts from all 
biological samples and labeling them with one of the Cy dyes, usually Cy2. The 
internal standard was then run on the same gel as the other labeled protein 
samples, allowing every protein from all samples to be represented on the gel, 
therefore every protein within the samples can be linked to a common internal 
standard. The significance of the internal standard lies with the ability to 
normalise each sample to the internal standard on the same gel.  This in turn 
allows for the abundance of each protein sample in a biological sample to be 
expressed as a ratio to the corresponding spot in the internal standard. This 
normalisation grants accurate quantitation and accurate spot statistics as 
discussed in chapter 4.  
 For this experiment a minimal labelling technique was used. This method 
involves labelling protein at a low ratio of dye to protein, which means that at 
least one lysine is labelled per protein and approximately 2-5% of lysines are 
labelled (Unlu et al. 1997).  
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5.2 Methods 
5.2.1.  Preparation of mitochondria-enriched fraction from skeletal muscle. 
Gastrocnemius muscle tissue (3g wet weight) from 9-week old normal versus 
age-matched diabetic GK rats was cut into small pieces and homogenised in 20 
ml of buffer (220mM mannitol, 70mM sucrose, 20mM Hepes, pH 7.4), 
supplemented with 1 Roche PIC complete mini tablet per 10 ml of solution. The 
resulting mixture was centrifuged at 1,100g for 5 min at 4oC to remove cellular 
debris. The supernatant was retained. The pellet was re-suspended in 10 ml of 
homogenisation buffer and re-centrifuged as described above. Supernatants from 
the above separation steps were pooled and centrifuged at 7,000g for 15 min. 
The mitochondrial fraction was obtained as a pellet after repeated centrifugation 
steps at 20,000g for 15 min. The final mitochondria-enriched pellet was re-
suspended in 2D lysis buffer for DIGE analysis. Samples were adjusted to a pH-
value of 8.5. The protein content of individual samples was determined by the 
Bradford assay system. 
 
5.2.2  Fluorescent labelling of proteins  
Potential differences in the protein expression patterns of normal versus diabetic 
mitochondria were determined by difference in-gel electrophoresis (DIGE) using 
the CyDye DIGE fluor minimal dyes Cy3 and Cy5. DIGE dyes were reconstituted 
as a stock solution of 1mM in fresh dimethylformamide. The stock solution was 
diluted to a working solution of 0.2mM prior to fluorescent labelling. Samples of 
50 mg protein, representing each biological replicate, were minimally labelled 
  131
with 200 pmols of Cy3 working solution. A pooled sample consisting of equal 
quantities of protein from all replicates used in the experiment were labelled at 
200 pmol of Cy5 working solution to 50 mg of protein. The pooled fraction served 
as an internal standard. All samples were labelled at pH 8.5 with the appropriate 
amount of CyDye and after brief vortexing incubated on ice in the dark for 30 min. 
The labeling reaction was terminated by the addition of 1µl of 10 mM lysine per 
25 µg of muscle protein. Suspensions were briefly vortexed and then centrifuged 
at 12,000g for 10s and incubated on ice in the dark for 10 min. For gel 
electrophoretic separation, samples where loaded onto IPG strips with an equal 
volume of 2x sample buffer (7M urea, 2M thiourea, 65mM CHAPS, 2% 
ampholytes and 2% DTT) during rehydration.   
 
5.2.3.  Two-dimensional gel electrophoresis 
The fluorescently labelled subproteomes from the mitochondria-enriched fraction 
of normal (n=4) versus diabetic (n=4) skeletal muscle tissues were separated in 
the first dimension by isoelectric focusing and in the second dimension by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis, as previously optimized by 
our laboratory. IPG strips were rehydrated in rehydration buffer (7M urea, 2M 
thiourea, 4% (w/v) CHAPS, 1.2% Destreak agent and 2% (v/v) pH 3-10 
ampholytes) and 700 mg of protein sample for 12 hours. The first-dimension 
protein separation was conducted using the IPG strips on an Amersham IPGphor 
IEF system following the protocol previously described in detail [28]. First 
dimension strips were subjected to reduction and alkylation prior to second-
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dimension separation on 12.5% (w/v) slab gels. Gels were electrophoresed in an 
Amersham Ettan DALT-Twelve system. 
 
5.2.4  Mass spectrometric identification of muscle proteins 
In order to identify individual muscle-associated protein species, peptide mixtures 
were analysed by mass spectrometry on a Model 6430 Ion Trap LC/MS 
apparatus from Agilent Technologies (Santa Clara, CA, USA). Excision, washing, 
destaining and treatment with trypsin were preformed by a previously optimised 
method. Following tryptic digestion, generated peptides were obtained by 
removing supernatants from digested gel plugs. Further recovery was achieved 
by adding 30% acetonitrile/0.2% trifluoricacid to the gel plugs for 10 min at 37 0C 
with gentle agitation. Peptide-containing supernatants were pooled and samples 
dried through vacuum centrifugation. Peptide mixtures were then re-suspended 
in 10l mass spectrometry-grade water and 0.1% formic acid for identification by 
ion trap LC-MS analysis. Separation of peptides was performed with a nano flow 
Agilent 1200 series system, equipped with a Zorbax 300SB C18 5m, 4 mm 40nl 
pre-column and a Zorbax 300SB C18 5m, 43mm x 75m analytical reversed- 
phase column using the HPLC-Chip technology. Mobile phases utilized were A: 
0.1% formic acid, B: 50% acetonitrile and 0.1% formic acid. Samples (5l) were 
loaded into the enrichment at a capillary flow rate set to 2 l/min with a mix of A 
and B at a ratio 19:1. Tryptic peptides were eluted with a linear gradient of 10-
90% solvent B over 2 l/ min with a constant nano pump flow of 0.6 ml/min. A 1 
min post time of solvent A was used to remove sample carry over. The capillary 
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voltage was set to 1700 V. The flow and the temperature of the drying gas were 
4l/ min and 300oC, respectively. Database searches were carried out with 
Spectrum Mill Work Bench or Mascot MS/MS Ion search (Matrix Science, 
London, UK). 
 
 
5.3 Results 
In order to determine potential diabetes related changes in the mitochondrial 
subproteome from skeletal muscle, we have performed here a mass 
spectrometry-based proteomic analysis of the gastrocnemius muscle from normal 
versus diabetic Goto-Kakizaki (GK) rats. The non-obese GK animal model of type 
2 diabetes is a spontaneously diabetic rat, which shows clear signs of faulty 
insulin signalling within 4 weeks after birth (Portha et al., 1991).  As previously 
discussed in chapter 1,GK rats exhibit increased levels of blood glucose with no 
major changes in the concentration of non-fasting plasma insulin (Witte et al., 
2002). The proteomic analysis of the mitochondria-enriched fraction from normal 
versus diabetic skeletal muscles presented here has revealed a reduced 
expression of several mitochondrial enzymes, including NADH dehydrogenase, 
cytochrome b-c1 complex and isocitrate dehydrogenase. The altered abundance 
of these metabolic proteins might play a central role in the well-established 
decrease of mitochondrial oxidative phosphorylation in diabetic fibres. The 
proteomic results herein, shown in this report have demonstrated that the 
mitochondrial enzymes might aid in the pathological development of insulin 
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resistance.    
5.3.1 Isolation of Mitochondria and Validation of Enrichment 
 Gastrocnemius muscle from the well characterised control model, Wistar rat 
(W) and the diabetic Goto-Kakizaki (Gk) rat was used to enrich for mitochondrial 
muscle skeletal extracts. Two grams of muscle was homogenised from each 
animal (n=4 W, n=4 Gk) and mitochondria were obtained by differential 
centrifugation described in chapter 2.  
In this study undigested tissue was used to minimise the possibility of variation 
between samples. Common practice for the recovery of mitochondria from 
muscle tissues involves the exposure of the tissue to proteases in an attempt to 
break down the contractile apparatus. These methods often result in unequal 
digestion of tissues and therefore different amounts of mitochondria recovered as 
well as damage to the mitochondria. 
Purity of the mitochondria obtained was investigated by immunoblotting with 
markers for contractile apparatus (Myosin Fast), outer mitochondrial membrane 
(VDAC1), and inner mitochondrial membrane (Mitofilin). The western blot results 
show a decrease in the abundance of myosin fast, whereas the mitochondrial 
markers probed for show a significant increase in protein abundance in 
mitochondria-enriched fractions. These results give sufficient confidence that the 
enrichment procedure was successful and procedure for further analysis to 
occur.  
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5.3.2 DIGE Analysis of Mitochondria – Enriched Muscle Extracts 
We have applied here the DIGE method for the comparative analysis of the 
soluble mitochondrial subproteome from normal versus diabetic skeletal muscle 
tissue.  A period of optimisation of running conditions led to the conclusion that 
the pH gradient to be used would be one of pH 4-7. The pH 4-7 gradients were 
run on 24 cm IPG strips, which allowed for a greater degree of separation of 
proteins over a smaller pH range. Previous studies showed that few changes in 
protein abundance were observed across the more basic 6-11 pH range due to 
mitochondria being a notoriously acid organelle. Taking this into consideration 
resulted in the abandonment of the more basic range and the in depth analysis of 
the acid 4-7 pH range. Proteins were visualised with the highly sensitive cyanine 
dyes by difference gel electrophoresis. 25 mg of pooled internal standard and 25 
mg of individual samples were run on each gel. A total of 8 gels were run (n=4 W 
and n=4 Gk). From Figure 5.2 we can see a similar spot pattern between the 
individual samples and the pooled samples. The pooled samples are labelled 
with Cy5 dye and the individual samples with Cy3. The Cy dyes could be 
exchanged but it is important that all pooled samples are labelled with the same 
dye, and all individual samples are labelled likewise with the same dye.  
  136
 Figure 5.1: Comparative two-dimensional gel electrophoresis analysis of normal 
versus diabetic rat skeletal muscle. Shown is the 2-D DIGE analysis of the 
mitochondria-enriched fraction, using a pH 4-7 range in the first dimension. 
Individual panels represent Cy3-labelled gels of mitochondrial protein fractions 
from normal (A) and diabetic GK (C) skeletal muscle, as well as Cy5-labelled gels 
containing polled standards (B, D). The pH-values of the first dimension gel 
system and molecular mass standards (in kDa) of the second dimension are 
indicated on the top and on the left of the panels, respectively.  
This consistency will prevent any bias in dyes from sample to sample. From each 
gel two images are obtained, one from Cy3/samples and the other from 
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Cy5/pooled internal standard, using the Typhoon Trio variable image scanner. 
Analysis with Progensis samespot software revealed that 1374 spots where 
recognised across all gels. Following fluorescent labelling with CyDyes and high 
resolution two-dimensional gel electrophoretic separation of the mitochondria-
enriched fraction, densitometric scanning revealed a changed abundance in 24 
distinct protein spots. A reduced expression was found for 18 muscle associated 
protiens and an increased density for 6 proteins in the mitochondria-enriched 
fraction.  
5.3.3 Protein Identification 
 
The DIGE master gel shown, in Figure 5.3 outlines the position of the 24 2D-
spots with a changed abundance in diabetic preparations. Mass spectrometry 
identified the proteins with a decreased abundance as the glycolytic enzyme 
enolase (spots 1 and 7), the molecular chaperones Hsp60 (spot 3) and Hsp72 
(spot 8), muscle glycogen phosphorylase (spot 4), the mitochondrial enzyme 
NADH dehydrogenase (spots 5 and 12), subunit-1 of the cytrochrome b-c1 
complex (spot 6), phosphoglycerate kinase (spot 9), muscle creatine kinase (spot 
10), diacylglycerol kinase (spot 11), isocitrate dehydrogenase (spot 13), myosin 
binding protein H (spot 14), the mitochondrial Tu translational elongation factor 
(spot 16), the 78kDa glucose-regulated protein (spot 17) and the fast MLC1-f 
isoform of myosin light chain (spot 18). Interestingly, differential changes of 
individual 2d spots representing pyruvate dehydrogenase (spots 15 and 22) and 
ATP synthase (spots 2, 19 and 24) were obsereved. Increased proteins were 
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identified as triose phosphate isomerase (spot 20), phosphofructokinase (spot 
21) and pyruvate kinase (spot 23). 
 
 
Figure 5.2. Two-dimensional DIGE reference gel of diabetic rat skeletal 
muscle. Shown is a DIGE reference gel of the mitochondria-enriched fraction 
from rat skeletal muscle, used for the mass spectrometric identification of 
proteins with a differential expression profile. The pH-values of the first dimension 
gel system and molecular mass standards (in kDa) of the second dimension are 
indicated on the top and on the left of the panel, respectively. Identified muscle 
proteins are marked by circles and are numbered 1 to 24. See Table 1 for a 
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detailed listing of proteins that exhibited a diabetes-associated change in their 
abundance. 
The 24 spots shown to have a fold change in protein abundance of greater than 
+/- 1.4 were identified by liquid chromatography mass spectrometry. Table 5.1 
correlates spot numbers on the DIGE master gel with the proteomic information 
on individual protein species as determined by mass spectrometry. The table lists 
the protein name, accession number, predicted isoelectric point, predicted 
molecular mass, number of matched peptides, mascot score, percent sequence 
coverage and fold change. 
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Table 5.1:  List of identified proteins that exhibit a changed abundance in 
mitochondria‐enriched fraction from diabetic skeletal muscle 
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1 enolase 3 gi|126723393 7.08 47332 17 314 44 -4.5 
2 
subunit d of 
mitochondrial H-ATP 
synathase gi|220904 5.78 18828 3 74 16 -3.3 
3 
Heat shock protein 
(Hsp60) precursor gi|56383 5.11 61101 5 100 12 -3.2 
4 
glycogen 
phosphorylase, 
muscle form gi|158138498 6.65 97749 10 112 13 -3.1 
5 
NADH 
dehydrogenase 
[ubiquinone] iron-
sulfur protein 8, 
mitochondrial gi|157821497 5.87 24419 6 56 25 -2.9 
6 
cytochrome b-c1 
complex subunit 1 
mitochondrial 
precursor   5.57 53511 9 241 19 -2.7 
7 beta-enolase gi|126723393 7.08 47332 17 206 44 -2.6 
8 
dna-k-type molecular 
chaperone Hsp 72-
psf-rat gi|347019 5.43 71116 12 113 17 -2.6 
9 
phosphoglycerate 
kinase 1  gi|40254752 8.02 44916 9 96 29 -2.5 
10 
creatine kinase M-
type gi|6978661 6.57 43224 7 111 17 -2.4 
11 
similar to 
diacylglycerol kinase, 
delta 130kDa isoform 
1 (predicted), isoform 
CRA_d gi|149037714 8.09 126993 2 50 1 -2.3 
12 
NADH- ubiquinone 
oxidoreductase 75 
kDa subunit, 
mitochondrial 
precursor gi|53850628 5.65 80348 2 44 4 -2.2 
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13 
isocitrate 
dehydrogenase 
[NAD] subunit alpha, 
mitochondrial 
precursor gi|16758446 6.47 40052 7 198 22 -2.2 
14 
myosin binding 
protein H gi|38303941 6 53044 7 177 23 -2.1 
15 
pyruvate 
dehydrogenase E1 
component subunit 
beta, mitochondrial 
precursor gi|56090293 6.2 39305 11 294 34 -2.1 
16 
Tu translation 
elongation factor, 
mitochondrial, 
isoform CRA_d gi|149067905 7.65 44023 2 74 10 -2 
17 
78kDa glucose-
regulated protein 
precursor gi|25742763 5.07 72476 2 60 4 -2 
18 
myosin light chain 
MLC1-f gi|205485 4.99 20795 15 200 67 -2 
19 
F1-ATPase beta 
subunit gi|203033 5.07 38747 4 187 12 2 
20 Tpi1 protein  gi|38512111 7.07 27223 10 152 59 2.1 
21 
phosphofructokinase, 
muscle  gi|62825891 8.07 86159 5 89 7 2.2 
22 
pyruvate 
dehydrogenase E1 
component subunit 
beta, mitochondrial 
precursor gi|56090293 6.2 39305 3 37 10 2.6 
23 
pyruvate kinase 
isozymes M1/M2 gi|16757994 6.63 58303 13 283 30 2.7 
24 
ATP synthase , H+ 
transporting, 
mitochondrial F1 
complex, beta 
polypeptide, isoform 
CRA_b gi|149029719 6.43 23434 8 94 53 3.1 
 
 
5.4 Discussion  
Abnormal mitochondrial functioning has been implicated to play a central role in 
the molecular pathogenesis of insulin resistance and contractile weakness in 
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diabetic skeletal muscle tissues (Dumas et al., 2009). The proteomic DIGE 
analysis of the mitochondria-enriched fraction presented here confirms a 
disturbed protein expression pattern in the mitochondrial subproteome from GK 
gastrocnemius muscle. Our previous proteomic survey of crude total extracts 
from diabetic GK muscle had identified moderate differential expression patterns 
in 21 protein species. The diabetic phenotype seems to be associated with a 
generally altered composition of the muscle protein complement, affecting 
especially glucose, fatty acid, nucleotide and amino acid metabolism, as well as 
the detoxification mechanisms (Mullen et al., 2010). With respect to changes in 
mitochondria, a reduction in NADH dehydrogenase, cytochrome b-c1 complex, 
and isocitrate dehydrogenase agrees with previously reported decreased 
phophorylation in type 2 diabetes (Lowell et al., 2005, Zorzano et al., 2009 ).     
The lower concentration of the molecular chaperones Hsp60 and Hsp72 
indicates an impaired cellular stress response in GK muscle tissue, which might 
weaken the defense mechanisms of metabolically challenged skeletal muscles. 
Reduced levels of muscle glycogen phosphorylase could have a negative effect 
on the proper utilisation of stored glycogen and a lower concentration of creatine 
kinase may negatively affect the creatine kinase shuttle. Both reductions in key 
metabolic components probably worsen the bioenergetic status of diabetic fibres 
and explain the contractile weakness in certain skeletal muscles from patients 
with type 2 diabetes (Andersen et al., 2004, Park et al., 2006). Interestingly, 
glycolytic marker enzymes were differentially affected in GK muscle. The 
increased density of triose phosphate isomerase, phosphofructokinase and 
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pyruvate kinase would suggest a higher glycolytic flux rate in tissues with a 
reduced mitochondrial content. Phosphofructokinase and pyruvate kinase 
represent the rate-limiting steps of glycolysis, this alteration might be interpreted 
as a glycolytic shift that has previously been described in obese skeletal muscle 
(Hittel et al., 2005). On the other hand, the enzymes enolase and 
phosphoglycerate kinase are reduced in GK tissue, which might be associated 
with the multi-functionality of many glycolytic elements (Ohlendieck et al., 2010).  
The enzyme diacylglycerol kinase catalyses the conversion of diacylglycerol to 
phosphatidic acid and uses ATP as a source of the phosphate. Thus reduced 
ATP levels in diabetic muscle tissues due to reduced content of functional 
mitochondria could affect this enzyme. Altered levels of the fast MLC1-f isoform 
of myosin light chain and myosin binding protein H indicate a certain degree of 
remodeling of the contractile apparatus. However, since this subproteomic 
analysis was carried out with a mitochondria-enriched fraction it is difficult to 
interpret changes in regulatory elements acto-myosin filaments. Compensatory 
mechanisms to counter-act the loss of mitochondrial functioning appear to be an 
increase in certain isoforms of pyruvate dehydrogenase and ATP synthase 
(Dumas et al., 2009). 
5.4.1 Conclusions 
In conclusion, DIGE analysis of mitochondria-enriched muscle extracts from 
normal versus diabetic show increased abundance of several key mitochondrial 
proteins. Alterations in the mitochondrial proteome include proteins from different 
metabolic pathways. The novel candidate proteins with a changed expression 
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level in the mitochondria-enriched fraction, as shown in this proteomic survey of 
the GK rat model of non-obese type 2 diabetes, should be helpful for 
complementing the biomarker signature of diabetes mellitus (Korc et al., 2003., 
Sundsten et al., 2009). Changes in the functioning and/or density of 
mitochondrial enzymes may be useful for the identification of new therapeutic 
targets, the development of better diagnostic criteria, the improved monitoring of 
disease progression and biomedical evaluation of experimental regimes. 
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Chapter 6  
Analysis of Diabetic 
skeletal muscle proteins 
using non-ionic 
detergent phase 
extraction of 
gastrocnemius tissue. 
 
  146
6 Analysis of Diabetic skeletal muscle proteins using 
non-ionic detergent phase extraction of gastrocnemius 
tissue. 
6.1 Introduction 
Abnormal glucose handling has emerged as a major clinical problem in millions 
of diabetic patients world wide (King et al., 1998). Insulin resistance impinges 
especially on contractile fibres, making abnormal glucose handling in skeletal 
muscle tissues a key issue for treating side effects of type 2 diabetes (Phielix et 
al., 2008). High levels of circulating free fatty acids, an increased intramyocellular 
lipid content, impaired insulin-mediated glucose uptake, diminished mitochondrial 
functioning and an overall weakened metabolic flexibility are pathobiochemical 
hallmarks of diabetic skeletal muscles.  
As membrane proteins are reliable drug targets and biomarkers their successful 
enrichment was the aim of this study. Nonionic detergent phase extraction was 
carried out with Triton X-114. This detergent is ideal for the phase partitioning of 
soluble and membrane-associated proteins into aqueous and detergent phases, 
respectively.  
6.1.1 Membrane proteins  
Biological membranes form an essential barrier between living cells and their 
external environments. Intracellular organelles are compartmentalized via 
biological membranes. For example the inner and outer membranes of the 
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mitochondria, the membranes that envelope the nucleus, lysosomes and 
secretory vesicles. These membranes and the proteins embedded within have 
different and highly specialized functions, depending on their organ and tissue 
specific localizations.  
A different set of proteins within each membrane enables it to carry out the 
distinctive role of the membrane in question. Biological membranes are typically 
composed of 50% proteins by mass (Guidotti et al., 1972). The importance of 
membrane proteins is reinforced by the fact that they carry out the essential 
functions of the membrane.  
Membrane proteins are critical components of cellular structure and function, and 
constitute a particular sub-proteome that merits in-depth analysis. These proteins 
constitute over 30% of all cellular proteins and are predicted to be important 
pharmacological an therefore (replacement) biomarker targets for drug 
development (MacCoss et al., 2003). Due to their relatively high hydrophobicity 
and low abundance membrane proteins are infamously difficult to analyse on 
conventional 2D PAGE proteomic techniques (Gorg et al., 2004). 2D PAGE is an 
excellent method for the separation of soluble and less hydrophobic membrane-
associated proteins. It is however, clear that hydrophobic integral membrane 
proteins, especially those with multiple transmembrane domains, are under-
represented on 2D gels. This is due to several factors, including their poor 
solubility and tendency to aggregate and precipitate in aqueous media that are 
compatible with the first dimension separation, their generally basic pI values and 
their often relatively low abundance in whole cell and tissue extracts.  
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6.1.2 Detergent phase extraction 
Nonionic detergents are commonly used for the solubilization and 
characterization of integral membrane proteins. Most of the lipid molecules in 
contact with the hydrophobic domains of these proteins are replaced with the 
nonionic detergent which leads to the formation of a soluble protein detergent 
micelle mix (Tanford et al., 1976, Helenius et al., 1975). Several properties of this 
mixed micelle such as size and hydrophobicity will depend on the properties of 
the protein solubilized as well as the properties of the detergent used. 
Bordier et al. first described the detergent Triton X-114, in 1980. In this study he 
compared the ability of the Triton X-100 to enrich for membrane proteins with that 
for Triton X-114. Triton X-100 forms clear micellar solutions at room temperature. 
As the cloud point is approached (640C) the solution turns turbid and a 
microscopic phase separation occurs in the solution (Maclay et al., 1956). Over a 
gradient of increasing temperature, with 640C being the max, phase separation 
proceeds until two clear phases, one enriched and one depleted, are formed. 
Triton X-114 was shown to have a lower cloud point of 300C, which is a desirable 
trait as it promotes protein integrity post phase separation. It has also been 
reported that it forms micellar solutions n the same manor as its counterpart 
Triton X-100. 
6.1.3 Visualization and Identification. 
In this study 2D PAGE fluorescent RuBPs analysis was used to compare the 
diabetic versus the normal rat gastrocnemius muscle.  Following the gel 
electrophoretic separation of the aqueous and the detergent-extracted fraction 
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from skeletal muscle homogenates, proteins of interest with a changed 
abundance were identified by ESI LC/MS technology. Several new potential 
markers of the diabetic condition were identified which might be useful for the 
future establishment of a comprehensive biomarker signature for the diabetic 
state.  
6.2 Methods 
6.2.1. Nonionic detergent phase extraction of muscle proteins. 
Fractionation of crude skeletal muscle tissue preparations into an aqueous phase 
and a detergent-extracted phase was carried out as previously described for 
cardiac muscle (Donoghue, et al., 2008). Freshly dissected gastrocnemius 
muscle tissue (250 mg) from 3 Wistar and 3 GK rats were ground into a fine 
powder under liquid nitrogen using a pestle and mortar.Groound tissue was 
immediately added to 8ml of ice-cold phosphate buffered saline (PBS;0.9% (w/v) 
NaCl, 50mM sodium phosphate, pH 7.4) and 2 ml of 10% (v/v)  
Triton X-114 and left overnight at 40C on a rotary shaker. The suspended 
samples were centrifuged at 20,000 g for 30 min at 40C to remove tissue debris. 
The supernatant was incubated for 30 min at 370C and then centrifuged for 5000 
g at 250C to separate the detergent and aqueous phases. The aqueous top layer 
was removed to a fresh 50 ml tube to which 2 ml of 10% Triton X-114 was added. 
The lower detergent-extracted phase was resuspended in 8 ml of ice-cold PBS. 
Both samples were placed for 15 min at 370C, followd by a 15 min cebtrifuge spin 
at 5000 g and 250C. This process was repeated 3 times in order to wash each 
fraction and remove potential cross-contaminants. Differently separated proteins 
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were extracted from each phase by acetone precipitation at -200C for 1h. 
Following a centrifugation step at 5000 g for 30 min, precipitated proteins were 
resuspended in 1ml buffer and 200 l of DIGE-compatible lysis buffer. The total 
protein yield from starting material of 250 mg of skeletal muscle tissue was 5.16± 
0.38 mg in the Wistar AQ phase (n=4), 4.78±0.62 mg in the GK AQ phase (n=5), 
0.45± 0.10 mg in the Wistar DT phase (n=5), and 0.40 ± 0.09 mg in the GK DT 
phase (n=5). Protein concentration was determined by Bradford assay.  
6.2.2 Gel electrophoretic analysis 
For the comparative proteomic analysis of proteins fractionated into AQ phase 
and DT phase, ruthenium bathophenanthroline disulfonate (RuBPs). A stock 
solution of RuBPs dye was prepared as described by Rabilloud et al. Following 
overnight in fix solution (30% ethanol, 10% acetic acid), slab gels were then 
washed 3 times with 20% ethanol for 30 minutes. The gels were stained for 6 h in 
20% (v/v) ethanol containing 200 nM of the ruthenium chelate. The gels were re-
equilibrated twice for 10 minutes in distilled water prior to imaging.   
6.2.3 Expression analysis 
Following nonionic detergent phase extraction of muscle proteins, 2DE 
separation, protein expression changes between Wistar and  GK gastrocnemius 
samples from the AQ and DT fraction were analysed using Progenesis 
SameSpots analysis (SSA) software from Non Linear Dynamics (Newcastle upon 
Tyne, UK). Prior to analysis, individual gels were warped to a single master gel 
and further matched and normalized with non-gel spots manually filtered out on 
the basis of spot volume. SSA  was used to identify proteins of interest using the 
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following parameters: n=4; ANOVA p<0.05: and a power value of >0.8. Proteins 
with a significantly changed abundance were picked for tyrptic digestion from 
coomassie-stained preparative gels.  
6.2.4 Protein digestion 
Excised protein spots from 2-DE gels were added to 200 mM ammonium 
bicarbonate solution and incubated at 370C for 10 min with gentle agitation. 
Following a brief spin, a solution of 200 mM ammonium bicarbonate/ acetonitrile 
2:3 was added to each gel plug and left at 370C for 10 min with gentle agitation. 
Samples were spun again briefly and resuspended in 50 mM ammonium 
bicarbonate and left at 370C for 10 min with gentle agitation. Gel plugs were 
shrunk using 100% acetonitrile for 10 min at 370C. Proteins were digested over 
night at 370C with gentle agitation using 0.2 ng/μg of sequence grade-modified 
trypsin (Promega, Madison, WI, USA). Peptides were recovered by removing 
supernatants from digested gel plugs. Further peptide recovery was achieved by 
adding 30% acetonitrile/ 0.2% trifluoric acid to the gel plugs for 10 min at 370C 
with gentle agitation. Following a brief spin, supernatants were added to the initial 
peptide recovery following digestion. Exhaustive peptide recovery was achieved 
through the addition of 60% acetonitrile/0.2% tirfuoric acid to each plug for 10 min 
at 370C with gentle agitation. Supernatants were added to the peptide pool. 
Sample volume was reduced until dry through vacuum centrifugation. Samples 
were resuspended in 30μl od ultra-pure ddH2O and 0.1% formic acid for 
identification by mass spectrometry.  
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6.2.5 ESI LC-MS/MS analysis  
Nanoflow LC separation of tryptic peptides was preformed with a nanoflow 1200 
series system from Agilent Technologies (Santa Clara, CA, USA), equipped with 
a Zorbax 300SB C18 5μm , 4mm 4o nl pre-column and a Zorbax 300SB C18 
5μm, 43mm x 75μm analytical reversed phase column using HPLC-Chip 
technology. Samples were initially transferred with an aqueous 0.1% formic acid 
solution to a pre-column with a flow rate of 4ml/min for 3 min. Mobile phase A 
was 0.1% formic acid and mobile phase B 0.1% formic acid in acetonitrile. 
Peptides were separated with a gradient of 3-40% mobile phase B over 9 min at 
a flow rate of 400 μl/min followed by a 3 min wash with 90% of mobile phase B. 
Analysis of tryptic peptides was performed using and Agilent 6300 series ion trap 
LC mass spectrometer. All analyses were performed using positive nano-
electrospray ion mode. The MS survey scan was set between 100 and 2200 m/z 
with a duration of 0.5s/scan and the 3 most intense peptides further selected for 
MS analysis. Collision energy was ramped between 1500 and 4500 V based on 
the observed precursor mass over charge value and charge state. Spectra were 
processed and anlaysed by Spectrum Mill database search software (Agilent 
Technologies, Santa Barbara, CA). 
6.3. Results 
6.2.1 Nonionic detergent phase extraction for the proteomic analysis of 
diabetic skeletal muscle. 
The sub-proteomic investigation described here is based on the principle of 
nonionic detergent phase extraction (Bordier et al., 1980). A comparison of the 
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aqueous versus the detergent-extracted fraction from the GK rat versus Wistar 
rat gastrocnemius muscle tissue was carried out. Figure 6.1 outlines the 
experimental protocol used for the separation of skeletal muscle proteins by 
treatment with Triton X-114. Since phase separation with Triton X-114 occurs at 
temperatures above 220C, skeletal muscle protein fractionation was carried out at 
370C (Donoghue et al, 2008). The separation step resulted in an aqueous AQ 
phase enriched in hydrophilic proteins and a detergent DT phase with 
predominantly hydrophobic proteins. Despite repeated washing steps, phase 
transition approaches always result in a certain degree of cross-contamination 
between soluble and membrane-associated proteins. Extracted proteins were 
separated by standard 2DE and proteins of interest identified by LC/MS 
technology. 
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Figure 6.1: Nonionic detergent phase extraction of normal versus diabetic 
muscle tissue. The subcellular fractionation approach used in this subproteomic 
investigation is based on the principle of nonionic detergent phase extraction. 
The flow chart in panel (A) outlines the experimental protocol employed for the 
separation of skeletal muscle proteins by treatment with Triton X-114. The 
temperature-dependent separation step resulted in an aqueous (AQ) phase-
enriched in hydrophilic proteins and a detergent (DT) phase with predominantly 
hydrophobic proteins.   
6.2.2 Gel electrophoretic analysis of nonionic detergent phase extraction of 
muscle proteins 
Figure 6.2 illustrates the successful enrichment of typical membrane-associated 
skeletal muscle proteins in the detergent-extraction fraction and a soluble 
enzyme in the aqueous phase-extracted fraction. The 1-DE analysis of crude 
preparations versus the aqueous phase and detergent-extracted phase 
demonstrated the differing protein band pattern between the two main fractions 
following phase separation. Importantly, immunoblotting revealed a clear 
enrichment of the fast-twitch sarcoplasmic reticulum Ca2+-ATPase isoform 
SERCA 1 and the inner mitochondrial membrane-associated enzyme ATP 
synthase in the detergent-extracted fraction from both diabetic and normal 
gastrocnemius muscle tissue. In stark contrast, the soluble isoform of cytosolic 
malate dehydrogenase was found to be enriched in the aqueous phase from both 
diabetic and normal tissues. Following the initial evaluation of the nonionic 
detergent phase extraction method by 1DE, the aqueous and detergent fractions 
  155
were electrophoretically separated on large high-resolution 2D gels covering the 
3-10 pH range. Since silver staining exhibits a relatively limited dynamic range, 
the more discriminatory RuBPs method was employed for detailed determination 
of changes in protein abundance.  
 
6.2.3 RuBPs analysis of the diabetic muscle proteome 
Fluorescent staining is one of the most powerful techniques for conducting 
comparative expression studies of complex proteomes, making it an ideal route 
for sophisticated analysis of the detergent-enriched fraction from the 
gastrocnemius from diabetic and normal animal models. The staining protocol 
reported by Rabilloud (et al., 2001) was followed, and following scanning with an 
Amersham Typhoon Trio variable imager and with the help of Progenesis 2-D 
analysis software, 32 protein species out of 873 spots from the detergent 
enriched sample and 1328 on the aqueous enriched sample, detectable 2D spots 
were found to be differentially expressed. Master gels representing 
electrophoretically separated proteins from diabetic versus normal muscle fibres 
are shown in Figures 6.3 and 6.4. Proteins of interest were identified by ESI 
mass spectrometry.   
6.2.4 Proteomic profile of diabetic skeletal muscle 
A list of identified protein species with an altered abundance in the detergent-
extracted and aqueous fraction from diabetic versus normal rat gastrocnemius 
muscle is shown in Tables 6.1 (AQ) and 6.2 (DT). The tables summarizes the 
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results with respect to protein name, the protein accession number, mascot 
score, the number of matched peptide sequences, the percentage sequence 
coverage, the molecular mass, the pI value and the fold change of individual 
proteins affected during the weakening of muscle due to the diabetic state. 
Overall a decreased expression level was shown for 8 protein spots in the 
aqueous fraction and 7 protein spots in the detergent-enriched fraction. An 
increased concentration was found for 10 distinct protein species in the aqueous 
fraction and for 9 protein spots in the detergent-enriched fraction.  
In the DT fraction, protein species with an increased expression level were 
identified as ATP synthase alpha precursor, adenylate kinase isozyme 1, 
tropomyosin alpha-4 chain, glutathione-dependent dehydroascorbate reductase, 
3-mercaptopyruvate sulfertransferase, apolipoprotein A1, glyoxalase, cofilin 2 
and adenylate kinase. Differential effects on dissimilar 2D spots representing the 
same protein or protein complex were observed for pyruvate kinase, alpha-b 
crystallin, phosphoglucomutase-1, glyceraldehyse 3-phosphate dehydrogenase 
and rhoGDP-dissociation inhibitor 1.  
In the AQ fraction, proteins with an increased concentration were identified as 
heat shock protein 1, secernin 3, isoform CRA_a, Hsp 60 mitochondrial 
precursor, Parkinson disease protein 7, Coq 9, Peroxiredoxin 2, Hsp 5, NADH 
dehydrogenase (ubiquinone) Fe-S protein 1, Pyruvate dehydrogenase 
(lipoamide) beta and transferrin. Differential effects on dissimilar 2D spots 
representing the same protein or protein complex were observed for adenylate 
kinase isozyme 1, fructose-bisphosphate aldose A, NADH dehydrogenase, 
  157
ubiquinol-cytochrome c reductase core protein and dihydrolipoamide S-
acetyltransferase. The majority of identified proteins were found to be involved in 
mitochondrial metabolism, glycolysis, metabolic transportation and the cellular 
stress response.  
 
 
20kDa
pH3
220kDa
pH10
9 12 11
14
134
5
6
15
16
2
1
7 10
8
17
3
 
Figure 6.3: RuPB’s analysis of the aqueous fraction from normal versus diabetic 
rat skeletal muscle. Proteins with different expression levels are numbered 1-17 
and are marked by circles. See Table 6.1 for a detailed listing of aqueous phase-
extracted proteins with a changed abundance in diabetic fibres. The pH values of 
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the IEF system and molecular mass standards (in kDa) of the 2D gels are 
indicated on the top and on the left of the panels, respectively.  
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Figure 6.4: RuPB’s analysis of the detergent-extracted fraction from normal 
versus diabetic rat skeletal muscle. Proteins with different expression levels are 
numbered 1-17 and are marked by circles. See Table 6.2 for a detailed listing of 
detergent phase-extracted proteins with a changed abundance in diabetic fibres. 
The pH values of the IEF system and molecular mass standards (in kDa) of the 
2D gels are indicated on the top and on the left of the panels, respectively.  
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Table 6.1: RuBPs identified proteins with a changed abundance in the 
aqueous‐extracted fraction from normal versus rat gastrocnemius muscle 
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1 heat shock protein 1 gi|183396771 5.91 61091 22 388 39 3.5 
2 secernin 3, isoform CRA_a gi|149022245 5.72 48087 4 82 10 3.3 
3 
hsp 60 
mitochondrial 
precursor 
gi|109506917 6.36 94075 17 277 22 3 
4 Parkinson disease protein 7 gi|16924002 6.32 20193 11 166 46 2.8 
5 Coq 9 protein gi|51259441 5.5 35095 6 145 20 2.6 
6 peroxiredoxin 2 gi|8394432 5.34 21944 3 83 17 2.2 
7 heat shock protein 5 gi|25742763 5.07 72476 17 180 29 2.2 
8 
NADH 
dehydrogenase 
(ubiquinone) Fe-
S protein 1, 75 
kDa 
gi|53850628 5.65 80348 23 432 32 2.4 
9 
pyruvate 
dehydrogenase 
(lipoamide) beta 
gi|56090293 6.2 39305 20 338 38 2.1 
10 transferrin  gi|61556986 7.14 78550 18 216 24 1.5 
11 adenylate kinase isozyme1 gi|8918488 7.71 21446 9 120 39 -1.5 
12 NADH dehydrogenase  gi|53850628   80348 25 392 32 -1.6 
12 adenylate kinase isozyme1 gi|8918488 7.71 21646 9 128 35 -1.8 
13 
fructose-
bisphosphate 
aldose A 
gi|6978487 8.31 39791 29 499 57 -1.8 
14 
pyruvate 
dehydrogenase 
(lipoamide) beta 
gi|56090293 6.2 39305 9 193 30 -2.1 
15 
similar to alpha-
enolase (2-
phospho-D-
glycerate 
hydrolase) 
gi|109468300 5.81 54354 17 318 41 -2.2 
16 
ubiquinol-
cytochrome c 
reductase core 
protein 1 
gi|51948476 5.57 53511 23 313 33 -2.2 
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17 
dihydrolipoamide 
S-
acetyltransferase 
gi|78365255 6.76 67645 15 236 28 -2.4 
 
Table 6.2  RuBPs identified proteins with a changed abundance in the 
detergent‐extracted fraction from normal versus diabetic rat gastrocnemius 
muscle  
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1 pyruvte kinase gi|16757994 103 6.63 58303 2 10 -6.2 
2 alpha-B crystallin gi|6981420 71 4.71 26639 2 8 -5.4 
3 phosphoglucomutase-1 gi|77627971 148 6.14 61642 8 13 -4 
4 pyruvte kinase gi|16757994 237 6.63 58303 16 32 -3.8 
5 
NADH dehydrogenase 
(ubiquinone) Fe-S protein 
2 precursor gi|58865384 116 6.52 52934 2 4 -3 
6 
glyceraldehyde 3-
phosphate-
dehydrogenase gi|56188 208 8.43 36103 12 38 -2.5 
7 
rhoGDP-dissociation 
inhibitor 1 gi|31982030 208 5.12 23451 4 23 -2.1 
8 
ATP synthase alpha 
precursor gi|203055 236 9.22 58906 12 27 1.5 
9 
adenylate kinase 
isozyme 1 gi|8918488 218 7.71 21646 13 60 1.8 
10 
tropomyosin alpha-4 
chain gi|6981672 63 4.66 28550 7 20 1.9 
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11 
glutathione-dependent 
dehydroascorbate 
reductase  gi|12585231 55 6.25 27941 2 10 2.4 
12 
3-mercaptopyruvate 
sulfurtransferase gi|20304123 95 5.88 33209 4 20 2.6 
13 apolipoprotein A1 gi|6978515 98 5.52 30101 10 38 3.1 
14 glyoxalase gi|46485429 79 5.52 20980 3 14 3.4 
15 cofilin 2 gi|6671746 98 7.66 18814 6 41 4 
16 adenylate kinase gi|8918488 95 7.71 21646 4 20 6.4 
 
6.3 Discussion 
It is estimated that 30% of the human genome encodes for membrane-
associated proteins (Stevens et al., 2000). Proteins embedded in membranes 
represent crucial therapeutic targets (Hopkins et al., 2002) and as a result are of 
great importance. Subpreoteomics is the study of distinct subsets of proteins with 
usually results in a reduction in sample complexity (Cordwell, et al., 2000). This 
can be beneficial for the identification of low abundance signature molecules. 
Crude protein extracts is often unable to reveal the complete proteome 
complexity of the proteome in question and recently advances have been made 
in the proteomic profiling of large cellular structures, organelles and membrane 
domains from diverse systems (Tan et al., 2008, Sadowski 2008). 
Here we have successfully applied a nonionic detergent phase extraction method 
for the analysis of the aqueous versus the membrane-associated fraction from 
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skeletal muscle homogenates. Immunoblotting verified the enrichment of integral 
membrane proteins in the detergent-extracted fraction. A variety of muscle 
proteins in both phases showed varying degrees of alterations which lead to 
difficult interpretation of their role. The increase in Hsp1 and Hsp5 could be 
useful for future biomarker establishment. Identified muscle proteins with a 
change in abundance were shown to be involved in the stress response, 
glycolysis and metabolic transportation. These finding show that the condition 
experienced by the Goto-Kakizaki rat is of a weak pathology and of a generally 
mild protein expression disturbance. The proteomic findings presented here 
suggest that a generally mildly perturbed protein expression pattern which affects 
mainly metabolic pathways is of key importance to the pathology of diabetic 
skeletal muscle tissue.      
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7 General Discussion 
Type 2 diabetes is a metabolic state in which glucose is not retrieved from the 
blood efficiently. Insulin resistance is common in patients who experience high 
blood glucose levels. Often, the cells in the pancreas attempt to meet the 
increasing glucose levels of prediabetics. However these demands eventually 
exhaust the expanded cells and results in  cell apoptosis and high blood 
glucose levels.  Without Insulin production, blood glucose levels remain high and 
complications such as glucotoxicity ensue.  
 
Normally insulin binds to insulin receptors on the surface of the target organ cells 
resulting in a series of cellular events that promote intracellular glucose transport 
and therefore metabolism. After a period of compensated insulin resistance 
impaired glucose tolerance develops despite an increase in in insulin 
concentration as insulin resistance increases.  It is poorly understood how 
abnormal tissue sensitivity to insulin causes decreased skeletal muscle strength, 
particularly in older patients with type 2 diabetes. Fatty acid metabolism has a 
profound influence on diabetic side effects. Type 2 diabetes is associated with 
high levels of circulating free fatty acids, increased intramyocellular lipid content, 
diminished mitochondrial functioning and a weakened metabolic flexibility in 
skeletal muscle. This thesis has attempted to further understand the mechanisms 
of the diabetic state and to identify potential biomarkers of the condition, in 
context with the current understanding of the disease. This has been done by the 
use of rodent models to study human muscle degeneration, which is common 
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practice, as the Goto-Kakizaki rat model has been well established as a viable 
model of the type 2 diabetic diseases. 
Proteins are the biological effector molecules of the cell. Proteomics is the large-
scale and high throughput biochemical approach to study entire protein 
complements (de Hoog, et al., 2004). The principle technique used for protein 
separation and identification is 2D PAGE coupled with mass spectrometry. There 
are numerous constraints to the 2D technology. For example the main limitation 
encountered during this project was the under-representation of hydrophobic 
proteins on 2D gels. Also restrictions due to the pH ranges and masking of 
proteins have been an issue throughout this study.  
Skeletal muscle is responsible for approximately 80% of all insulin mediated 
glucose disposal. As a result of this fact skeletal muscle was used throughout this 
project as the tissue of choice in a bid to better understand the mechanisms 
behind the disease and disease progression.  
2D gel electrophoresis is a powerful tool of separation that aids in the 
development of a greater understanding of protein expression. When teamed 
with mass spectrometric techniques the two can result in the total analysis of 
whole proteomes. It is important to mention that significant periods of 
optimization (ranging from 1-3 months) are required to perfect techniques with 
large amounts of variables. Running conditions of both first and second 
dimensions, optimum LCMS gradients and sample digestions, sample 
preparations and sub-cellular enrichments, all require considerable stages of 
development. Many elements such as hydrophobicity of a sample (LCMS), salt 
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content (IEF), and lipid content (sample preparation), play noteworthy roles in the 
evolution of such methods.   
7.1 Conclusion  
Type 2 diabetes is a complex and difficult to understand metabolic state with a 
large number of underlying factors. Of these, several were identified by 
proteomics to be important in the pathology of skeletal muscle. The most 
significant changes where to muscle-associated proteins involved in glycolysis, 
the citric acid cycle, oxidative phosphorylation, lipolytic catabolism, oxygen 
transportation, the contractile apparatus and the stress response. The work 
reported in this thesis resulted in the identification of several potential biomarkers 
of diabetes associated muscle weakness, which with further study could provide 
means of tracking progression and therefore possible markers for early 
diagnosis, as well as therapeutic targets for type 2 diabetes.  The sub-proteomic 
analysis herein, suggests a mainly metabolic alteration in diabetic skeletal 
muscle tissue. This is evident from the data in chapter 5 which shows an altered 
abundance of such proteins as triose phosphate isomerase, phosphofructokinase 
and pyruvate kinase, all of which presented at a higher abundance than in the 
control animal model. The increased abundance insinuates a higher glycolytic 
flux rate in tissues with reduced mitochondrial content, which is indicative of a 
compensatory mechanism for the drop in the number of the organelle in question. 
Proteins involved in metabolism were found to have an altered expression in both 
whole cell lysate analysis of skeletal muscle as well as sub-proteomic analysis. 
This is suggestive to a mild but significant change in muscle metabolism through 
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glycolysis. In chapter 3, the protein with the greatest fold change was identified 
as monoglyceride lipase. This enzyme converts monoacylglycerides to free 
fatty acids and glycerol. It does so by mediating a critical step in the hydrolysis 
of stored triglycerides (Zechner et al., 2009) and its up-regulation might represent 
increased energy utilization by the lipolytic pathway in glucose-starved muscle 
tissues. More detailed biochemical studies have to be carried out to determine 
the general suitability of monoglyceride lipase as a muscle marker of non-obese 
diabetes. However, it is clear that insulin resistance results in a lack of glucose 
uptake by muscle cells, which in turn has an effect on other metabolic pathways 
such as gluconeogenesis, triacylglycerol hydrolysis, fatty acid oxidation and 
ketone body formation.  
The data presented in chapter 4 showed a significant increase in αβ-crystallin 
and Hsp27. Hsps of low molecular mass have specific cytoprotective functions 
which include the prevention of deleterious protein aggregation and the 
modulation of intermediate filament assembly. These findings are particularly 
informative as Hsp 27 associates with alpha- and beta-tubulin, and so is 
therefore involved in the assembly of the contractile apparatus. These 
small chaperone proteins were shown to be up-regulated in diabetic 
muscle tissue. The results presented here confirm the drastic effects of 
type 2 diabetes on voluntary contractile fibres. 
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 7.2 Future Prospects 
The most important long-term goal of proteomic research is not simply to 
catalogue protein components and define their molecular interaction but to 
understand how changes in protein expression and function alter and contribute 
to biological homeostasis, disease states and cellular pathways. The proteome is 
a complex and highly dynamic body, which experiences changes in expression 
due to both environmental and internal cues, such as growth, development, and 
cell division. For example the human genome constitutes of approximately 
25,000 genes, but it is believed that over one million functionally distinct protein 
components are encoded for by these genes. This is thought to be due to post-
translational modifications and alternative splicing (Zuo and Speicher 2002).    
There are many potential directions type 2 diabetic studies could take. A 2D 
PAGE study of cardiac tissue from both the normal Wistar rat and the GK 
diabetic rat would provide a in depth look at the cardiac conditions experienced 
by type 2 diabetes sufferers.    
Another avenue to explore would be to compare the non-obese GK animal model  
with that of the obese Zucker rat, which experiences obesity which influences the 
progression of the metabolic condition. 
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